<?xml version="1.0" encoding="UTF-8"?>
<svg height="741.342" width="4324.192" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="95.358" x="56.523,60.771,62.603,66.435,70.179,74.099,76.875,80.451,83.027,84.859,87.435,91.435,94.011,95.843,99.675,101.27499999999999,104.088,108.336,110.168,113.328,117.08800000000001,119.962,122.29,126.122,129.698,132.274,136.602,139.178,142.378,145.19,147.518,151.846,154.406,157.266,159.842,164.258,168.258,171.1,175.596,179.596,183.428,187.428,189.26,193.587,198.083,204.747,208.63,213.046,215.606,218.495,222.823,225.143,228.02,232.852,237.18,239.02,241.853,247.685,251.685,254.261,258.26099999999997,261.072,264.904,269.32,273.152,274.984,278.728,282.144,286.144" svgx:width="0.53,0.23,0.48,0.47,0.49,0.55,0.45,0.32,0.23,0.32,0.5,0.32,0.23,0.48,0.2,0.55,0.53,0.23,0.4,0.47,0.55,0.29,0.48,0.45,0.32,0.54,0.32,0.4,0.55,0.29,0.54,0.32,0.55,0.32,0.55,0.5,0.55,0.56,0.5,0.48,0.5,0.23,0.54,0.56,0.83,0.5,0.55,0.32,0.55,0.54,0.29,0.55,0.6,0.54,0.23,0.55,0.73,0.5,0.32,0.5,0.55,0.48,0.55,0.48,0.23,0.47,0.43,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">RIFLE criteria. Risk factors for the development of AKI were analyzed</text>
   <text y="104.315" x="56.523,60.355,62.187,66.027,68.371,70.203,74.531,78.947,80.779,83.939,86.515,88.347,91.94699999999999,94.28,96.856,100.856,105.272,107.848,111.848,115.008,118.168,120.0,124.328,128.728,131.074,134.906,139.322,143.154,144.986,148.73,151.89,153.722,156.882" svgx:width="0.48,0.23,0.48,0.55,0.23,0.54,0.55,0.23,0.4,0.32,0.23,0.45,0.55,0.32,0.5,0.55,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.48,0.55,0.48,0.23,0.47,0.4,0.23,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">via logistic regression analysis.</text>
   <text y="113.329" x="56.523,61.019,65.099,68.427,72.923,74.923,77.667,80.901" svgx:width="0.56,0.51,0.42,0.56,0.25,0.34,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Results:</text>
   <text y="113.329" x="85.89,91.386,95.802,99.801,102.217,106.633,110.961,115.377,119.873,122.344,126.344,130.82399999999998,133.966,137.798,142.214,146.694,149.84,152.416,158.248,162.56799999999998,165.714,170.21,174.042,176.618,178.45,182.45,186.866,189.442,192.642,195.705,201.537,205.537,208.113,212.113,215.207,217.039,221.455,225.031,226.863,231.191,235.687,239.687,244.167,247.239,249.071,253.471,256.65,259.226,263.642,267.642,270.766,273.926,276.502,280.83,285.326,289.07" svgx:width="0.69,0.55,0.5,0.3,0.55,0.54,0.55,0.56,0.32,0.5,0.56,0.55,0.48,0.55,0.56,0.55,0.32,0.73,0.54,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.23,0.55,0.45,0.23,0.54,0.56,0.5,0.56,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.4,0.32,0.54,0.56,0.47,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">One-hundred and two patients were included in the study.</text>
   <text y="122.344" x="56.523,60.435,64.851,68.851,71.83,76.158,79.99,83.99,86.566,90.398,92.23,94.07000000000001,97.002,98.833,103.249,106.825,108.657,113.153,117.153,121.569,125.145,129.14499999999998,132.095,136.423,138.743,141.789,146.621,150.949,152.78900000000002,155.792,161.624,165.456,168.65599999999998,171.609,175.689,179.769,181.345,185.425,188.391,194.71099999999998,197.745,199.993,204.393,205.966,210.686,212.258,216.338,220.418,222.666,224.266,227.282,231.114,235.53,240.01,242.986,245.562,249.978,253.81,256.37,259.371,263.699,266.019,269.065,272.225,276.225,280.057,284.057,286.633" svgx:width="0.49,0.55,0.5,0.55,0.54,0.48,0.5,0.32,0.48,0.23,0.23,0.55,0.23,0.55,0.45,0.23,0.56,0.5,0.55,0.45,0.5,0.55,0.54,0.29,0.55,0.6,0.54,0.23,0.55,0.73,0.48,0.4,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.28,0.55,0.55,0.59,0.55,0.51,0.51,0.28,0.2,0.55,0.48,0.55,0.56,0.55,0.32,0.55,0.48,0.32,0.55,0.54,0.29,0.55,0.4,0.5,0.48,0.5,0.32,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">The overall incidence of AKI was 77,5 % (n = 79), and that of severe</text>
   <text y="131.358" x="56.523,61.355,65.683,67.52300000000001,70.186,76.018,79.85,83.05,85.663,89.743,93.823,95.399,99.479,102.161,108.481,111.175,113.423,117.82300000000001,119.452,124.172,125.745,129.825,133.905,136.153,137.753,140.429,145.925,150.32500000000002,153.014,157.342,161.758,163.59,167.422,171.254,173.83,175.662,179.494,182.07,186.07,188.674,192.506,196.922,200.754,202.586,206.33,209.49,211.322,214.482,216.082,218.722,222.553,226.969,230.969,233.689,237.521,241.936,246.416,249.109,252.269,256.269,260.765,263.341,265.173,268.773,271.39,274.55,278.966,283.294,286.87" svgx:width="0.6,0.54,0.23,0.55,0.73,0.48,0.4,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.28,0.55,0.55,0.59,0.55,0.51,0.51,0.28,0.2,0.55,0.69,0.55,0.55,0.54,0.55,0.23,0.48,0.48,0.32,0.23,0.48,0.32,0.5,0.55,0.48,0.55,0.48,0.23,0.47,0.4,0.23,0.4,0.2,0.55,0.48,0.55,0.5,0.55,0.48,0.55,0.56,0.55,0.4,0.5,0.56,0.32,0.23,0.45,0.55,0.4,0.55,0.54,0.45,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">AKI was 34,3 % (n = 35). On univariate analysis, age and septic shock</text>
   <text y="140.315" x="56.523,60.099,64.427,67.003,69.579,73.579,75.411,79.243,81.818,85.72,90.2,93.203,96.363,98.195,102.611,107.027,108.859,111.187,113.019,116.595,120.427,124.843,127.332,129.164,132.92399999999998,135.893,141.725,143.557,146.133,150.53300000000002,153.468,156.628,160.628,164.46,168.46,171.036,175.036,177.96,182.792,187.12,188.96,191.906,196.402,200.234,202.81,204.642,208.642,213.058,215.634,218.83399999999997,221.726,223.974,228.45399999999998,230.06,234.78,236.353,240.433,242.008,246.088,250.168,254.248,255.84799999999998,258.747,263.22700000000003,264.813,269.533,271.163,275.242,276.818,280.898,284.978,289.058" svgx:width="0.45,0.54,0.32,0.32,0.5,0.23,0.48,0.32,0.5,0.56,0.55,0.4,0.23,0.55,0.55,0.23,0.29,0.23,0.45,0.48,0.55,0.32,0.23,0.47,0.55,0.73,0.23,0.32,0.55,0.55,0.4,0.5,0.48,0.5,0.32,0.5,0.55,0.6,0.54,0.23,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.28,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.51,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.51,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">correlated significantly with severe AKI patients (p = 0,042, p = 0,001,</text>
   <text y="149.33" x="56.523,59.099,63.099,66.259,70.755,74.755,78.236,80.812,82.644,86.476,90.476,92.308,96.052,98.3,99.89999999999999,102.557,106.885,110.64500000000001,113.329,119.993,124.321,126.153,128.729,130.561,134.393,138.225,140.801,142.633,146.465,149.041,153.041,155.679,157.511,161.839,166.255,168.087,171.247,173.823,175.655,179.255,181.928,184.504,188.504,192.919,195.495,199.495,202.655,205.815,207.647,211.975,216.375,219.005,222.837,227.253,231.085,232.917,236.661,239.82,241.652,244.812,246.412,249.052,252.212,256.212,260.708,263.284,265.116,268.716,271.39,274.55,278.966,283.294,286.869" svgx:width="0.32,0.5,0.4,0.56,0.5,0.45,0.32,0.23,0.48,0.5,0.23,0.47,0.28,0.2,0.55,0.54,0.47,0.55,0.83,0.54,0.23,0.32,0.23,0.48,0.48,0.32,0.23,0.48,0.32,0.5,0.55,0.23,0.54,0.55,0.23,0.4,0.32,0.23,0.45,0.55,0.32,0.5,0.55,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.48,0.55,0.48,0.23,0.47,0.4,0.23,0.4,0.2,0.55,0.4,0.5,0.56,0.32,0.23,0.45,0.55,0.4,0.55,0.54,0.45,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">respectively). By multivariate logistic regression analysis, septic shock</text>
   <text y="158.344" x="56.523,62.355,66.187,69.387,72.397,74.973,79.389,83.389,86.457,90.785,95.201,97.033,100.793,103.805,105.637,110.053,114.548,118.548,123.044,127.044,131.46,135.956,139.956,144.372,146.93200000000002,149.953,152.529,154.361,157.521,161.28099999999998,164.353,166.681,170.513,174.089,176.665,180.992,183.552,186.633,188.961,193.289,195.849,198.935,202.511,206.839,208.671,210.503,213.663,216.239,218.071,222.487,224.903,226.735,231.151,235.559,239.887,243.463,247.463,251.94299999999998,255.004,258.164,262.164,265.996,269.996,272.572,276.572,279.609,284.441,288.769" svgx:width="0.73,0.48,0.4,0.55,0.32,0.55,0.5,0.55,0.54,0.55,0.23,0.47,0.55,0.23,0.55,0.56,0.5,0.56,0.5,0.55,0.56,0.5,0.55,0.32,0.55,0.32,0.23,0.4,0.47,0.55,0.29,0.48,0.45,0.32,0.54,0.32,0.55,0.29,0.54,0.32,0.55,0.45,0.54,0.23,0.23,0.4,0.32,0.23,0.55,0.3,0.23,0.55,0.56,0.54,0.45,0.5,0.56,0.55,0.4,0.5,0.48,0.5,0.32,0.5,0.55,0.6,0.54,0.23" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">was the only independent risk factor for colistin-induced severe AKI</text>
   <text y="167.358" x="56.523,58.771,64.267,68.50699999999999,70.866,74.946,76.522,80.602,84.682,88.762,91.106,93.354,97.433,99.009,103.089,107.169,111.249,113.612,117.612,120.019,124.099,128.179,129.755,133.835,137.915,141.995,144.243,145.843,148.138,152.618,154.205,158.925,160.554,164.634,166.21,170.29,174.37,178.45,180.698" svgx:width="0.28,0.69,0.53,0.55,0.51,0.2,0.51,0.51,0.51,0.55,0.28,0.51,0.2,0.51,0.51,0.51,0.55,0.5,0.55,0.51,0.51,0.2,0.51,0.51,0.51,0.28,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.51,0.28,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(OR 8,580 [1,868 – 39,417]; p = 0,006).</text>
   <text y="176.316" x="56.523,61.187,65.683,70.179,73.755,75.755,80.251,83.578,85.578,89.972,94.468,97.796" svgx:width="0.58,0.56,0.56,0.45,0.25,0.56,0.42,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Conclusions:</text>
   <text y="176.316" x="102.501,107.301,110.268,114.684,116.516,120.932,125.33200000000001,128.24,130.071,134.487,138.063,139.895,144.391,148.391,152.807,156.383,160.383,163.219,167.547,169.867,172.744,176.32,180.648,182.48,184.312,187.472,190.048,191.879,196.295,198.711,200.543,204.959,209.367,213.695,217.271,221.271,225.75099999999998,228.7,233.532,237.86,239.70000000000002,242.533,247.029,251.029,253.357,255.189,259.605,263.605,268.08500000000004,270.993,275.489,279.24899999999997,282.105,286.353,288.185" svgx:width="0.6,0.55,0.55,0.23,0.55,0.55,0.55,0.23,0.55,0.45,0.23,0.56,0.5,0.55,0.45,0.5,0.55,0.54,0.29,0.55,0.45,0.54,0.23,0.23,0.4,0.32,0.23,0.55,0.3,0.23,0.55,0.56,0.54,0.45,0.5,0.56,0.55,0.6,0.54,0.23,0.55,0.56,0.5,0.29,0.23,0.55,0.5,0.56,0.55,0.56,0.47,0.55,0.53,0.23,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">A high incidence of colistin-induced AKI defined by RI-</text>
   <text y="185.33" x="56.523,60.355,64.099,68.019,71.716,75.292,77.868,79.7,82.276,86.276,88.852,90.684,94.524,98.249,100.081,103.281,106.979,111.307,115.803,118.963,122.963,125.539,129.371,133.371,137.851,141.562,143.394,147.794,151.54,155.116,157.692,159.524,162.1,163.932,167.508,171.34,173.172,175.004,178.76399999999998,182.438,184.27,186.102,187.942,191.679,196.175,200.007,202.583,204.414,208.414,212.83,215.406,218.566,220.166,223.824,227.736,231.736,236.232,238.808,240.64,244.23999999999998,247.919,251.079,255.495,259.823,263.399,267.159,270.879,272.711,275.911,279.61,282.186,286.602" svgx:width="0.48,0.47,0.49,0.55,0.45,0.32,0.23,0.32,0.5,0.32,0.23,0.48,0.55,0.23,0.4,0.55,0.54,0.56,0.4,0.5,0.32,0.48,0.5,0.56,0.55,0.23,0.55,0.55,0.45,0.32,0.23,0.32,0.23,0.45,0.48,0.23,0.23,0.47,0.55,0.23,0.23,0.23,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.2,0.55,0.49,0.5,0.56,0.32,0.23,0.45,0.55,0.4,0.55,0.54,0.45,0.47,0.55,0.23,0.4,0.55,0.32,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">FLE criteria is observed in critically ill patients. Septic shock is the</text>
   <text y="194.344" x="56.523,60.851,65.267,67.099,70.85900000000001,74.267,78.099,81.931,84.507,86.339,90.171,94.667,96.499,100.499,103.917,105.749,110.165,114.661,118.661,123.157,127.157,131.573,136.069,140.069,144.485,146.947,148.779,152.539,156.018,159.85,163.01,166.17,170.498,174.074,175.906,179.738,182.314,186.236,190.71599999999998,194.229,200.061,201.893,204.469,208.869,212.314,215.474,219.474,223.306,227.306,229.882,233.882,237.316,242.148,246.476,248.316,251.772,253.604,258.02,262.516,266.844,270.42,274.42,278.90000000000003,282.386,286.882" svgx:width="0.54,0.55,0.23,0.47,0.55,0.48,0.48,0.32,0.23,0.48,0.56,0.23,0.5,0.55,0.23,0.55,0.56,0.5,0.56,0.5,0.55,0.56,0.5,0.55,0.32,0.23,0.47,0.55,0.48,0.4,0.4,0.54,0.45,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.4,0.5,0.48,0.5,0.32,0.5,0.55,0.6,0.54,0.23,0.55,0.23,0.55,0.56,0.54,0.45,0.5,0.56,0.55,0.56,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">only variable independently associated with severe AKI induced by</text>
   <text y="203.358" x="56.523,60.099,64.427,66.259,68.091,71.251,73.827,75.659,80.05900000000001,82.431,85.007,89.423,93.423,95.999,99.831,104.327,108.071" svgx:width="0.45,0.54,0.23,0.23,0.4,0.32,0.23,0.55,0.55,0.32,0.55,0.5,0.32,0.48,0.56,0.47,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">colistin therapy.</text>
   <text y="221.329" x="56.523,60.738,64.563,66.903,70.728,73.383,77.208,81.422,84.775,88.6" svgx:width="0.56,0.51,0.31,0.51,0.35,0.51,0.56,0.45,0.51,0.42" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:7.5px;stroke:none;">References</text>
   <text y="230.343" x="56.523,60.115,62.065000000000005,68.485,71.838,73.413,75.912,78.484,79.759,82.205,86.967,90.32,92.585,94.145,98.127,102.10199999999999,104.598,108.348,111.7,112.97500000000001,115.482,121.257,122.817,124.377,128.36,131.96,134.417,138.167,144.257,145.532,148.024,151.459,155.359,157.541,161.524,163.084,167.141,171.199,174.799,177.333,179.906,184.743,186.018,188.502,192.716,196.699,200.599,202.159,204.424,208.406,211.759,213.941,217.991,220.533,224.2,225.475,227.903,231.338,234.69,238.043,239.603,243.503,246.855,249.12,250.68,254.663,258.63800000000003,261.182,265.164,267.114,269.629,272.906,276.889,278.449,280.009,282.738,285.003,286.563" svgx:width="0.48,0.26,0.55,0.45,0.21,0.55,0.34,0.17,0.55,0.63,0.45,0.3,0.21,0.53,0.53,0.55,0.5,0.45,0.17,0.55,0.77,0.21,0.21,0.53,0.48,0.55,0.5,0.81,0.17,0.55,0.46,0.52,0.29,0.53,0.21,0.54,0.54,0.48,0.55,0.34,0.64,0.17,0.55,0.56,0.53,0.52,0.21,0.3,0.53,0.45,0.29,0.54,0.55,0.49,0.17,0.55,0.46,0.45,0.45,0.21,0.52,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.44,0.53,0.21,0.21,0.36,0.3,0.21,0.53" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">1) Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K: Evaluation of colistin</text>
   <text y="239.357" x="68.485,71.838,74.538,76.819,80.171,84.146,86.456,89.809,93.866,97.459,101.441,103.691,105.958,109.311,113.368,116.721,118.281,122.263,124.993,127.243,129.599,135.689,139.589,141.149,143.414,144.974,147.156,149.339,152.931,155.661,157.221,159.951,162.216,165.568,169.551,171.801,174.102,178.707,180.89,184.242,190.332,192.515,196.497,200.181,204.239,207.591,209.856,211.416,214.768,218.368,220.647,224.704,228.057,231.334,233.599,237.192,239.374,240.934,244.287,245.562,247.859,249.419,253.401,255.666,259.259,261.441,265.423,268.776,271.041,272.601,276.583,280.566,283.918" svgx:width="0.45,0.36,0.55,0.45,0.53,0.55,0.45,0.54,0.48,0.53,0.3,0.55,0.45,0.54,0.45,0.21,0.53,0.36,0.3,0.55,0.81,0.52,0.21,0.3,0.21,0.29,0.29,0.48,0.36,0.21,0.36,0.3,0.45,0.53,0.3,0.55,0.61,0.29,0.45,0.81,0.29,0.53,0.48,0.54,0.45,0.3,0.21,0.45,0.48,0.55,0.54,0.45,0.44,0.3,0.48,0.29,0.21,0.45,0.17,0.55,0.21,0.53,0.3,0.48,0.29,0.53,0.45,0.3,0.21,0.53,0.53,0.45,0.21" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">as an agent against multi-resistant Gram-negative bacteria. International</text>
   <text y="248.315" x="68.485,70.045,74.028,77.928,80.11,84.092,87.445,89.02,91.332,95.315,97.265,99.496,102.848,106.831,109.096,110.656,116.745,118.305,121.583,123.765,127.748,131.805,133.365,136.718,138.29299999999998,140.597,143.95,148.007,151.6,155.582,157.847,160.547,162.877,166.47,170.062,173.655,177.247,178.52200000000002,180.792,184.385,187.977,189.927,193.52,195.47,196.715,200.307,203.9,206.082,209.674,213.267" svgx:width="0.21,0.53,0.52,0.29,0.53,0.45,0.21,0.55,0.53,0.26,0.55,0.45,0.53,0.3,0.21,0.81,0.21,0.44,0.29,0.53,0.54,0.21,0.45,0.21,0.55,0.45,0.54,0.48,0.53,0.3,0.36,0.55,0.48,0.48,0.48,0.48,0.17,0.55,0.48,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.29,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">journal of antimicrobial agents 2005, 25(1):11-25.</text>
   <text y="257.329" x="56.523,60.115,62.065000000000005,68.485,72.153,73.713,79.788,83.395,85.967,87.242,90.765,94.118,97.71,101.30999999999999,104.881,108.549,113.236,114.51100000000001,118.034,121.784,125.766,129.741,133.341,136.776,138.05100000000002,141.562,145.312,148.664,150.23899999999998,153.808,158.495,159.77,163.276,167.491,169.051,170.611,174.593,176.153,179.43,182.783,184.35799999999998,187.937,191.214,195.197,198.549,200.732,204.084,207.362,209.626,213.219,215.401,216.961,219.798,222.063,223.623,226.9,229.6,233.177,236.529,240.512,244.562,248.144,250.326,251.886,254.616,257.766,261.296,263.246,266.599,269.876,272.141,276.124,278.306,281.006,284.653,288.636" svgx:width="0.48,0.26,0.55,0.49,0.21,0.81,0.55,0.34,0.17,0.55,0.45,0.48,0.48,0.55,0.49,0.63,0.17,0.55,0.5,0.53,0.53,0.55,0.46,0.17,0.55,0.5,0.45,0.21,0.55,0.63,0.17,0.55,0.56,0.21,0.21,0.53,0.21,0.44,0.45,0.21,0.55,0.44,0.53,0.45,0.29,0.45,0.44,0.3,0.48,0.29,0.21,0.36,0.3,0.21,0.44,0.36,0.55,0.45,0.53,0.54,0.55,0.29,0.21,0.36,0.42,0.55,0.26,0.45,0.44,0.3,0.53,0.29,0.36,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">2) Kim J, Lee KH, Yoo S, Pai H: Clinical characteristics and risk factors of</text>
   <text y="266.344" x="68.485,71.763,75.745,77.305,78.865,81.595,83.86,85.42,89.402,91.585,93.145,97.127,101.185,105.085,108.362,111.955,116.005,118.374,122.357,125.949,130.007,133.989,136.172,140.154,142.419,146.402,149.604,151.164,154.442,156.001,158.266,161.544,162.81900000000002,165.089,166.649,170.632,172.897,176.489,178.671,182.654,186.006,188.271,189.921,193.903,197.885,201.238,202.813,205.058,206.618,210.6,214.5,216.682,220.665,224.017,225.59199999999998,227.848,231.83,233.78,236.068,239.421,243.403,245.668,247.228,253.318,254.878,258.155,260.338,264.32,268.378,269.938,273.29" svgx:width="0.44,0.53,0.21,0.21,0.36,0.3,0.21,0.53,0.29,0.21,0.53,0.54,0.52,0.44,0.48,0.54,0.55,0.53,0.48,0.54,0.53,0.29,0.53,0.3,0.53,0.43,0.21,0.44,0.21,0.3,0.44,0.17,0.55,0.21,0.53,0.3,0.48,0.29,0.53,0.45,0.3,0.21,0.53,0.53,0.45,0.21,0.55,0.21,0.53,0.52,0.29,0.53,0.45,0.21,0.55,0.53,0.26,0.55,0.45,0.53,0.3,0.21,0.81,0.21,0.44,0.29,0.53,0.54,0.21,0.45,0.21" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">colistin-induced nephrotoxicity. International journal of antimicrobial</text>
   <text y="275.358" x="68.485,71.838,75.895,79.487,83.47,85.735,88.435,90.765,94.358,97.95,101.542,105.135,106.41000000000001,108.68,112.273,115.865,117.815,121.407,123.357,124.602,128.195,131.787,135.38,137.562,141.155,144.747,148.34" svgx:width="0.45,0.54,0.48,0.53,0.3,0.36,0.55,0.48,0.48,0.48,0.48,0.17,0.55,0.48,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.48,0.29,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">agents 2009, 34(5):434-438.</text>
   <text y="284.316" x="56.523,60.115,62.065000000000005,68.485,72.235,76.218,79.495,82.772,86.747,89.858,95.633,96.908,100.006,105.781,109.764,113.746,116.011,117.571,121.554,123.129,126.255,129.608,130.883,133.909,138.281,139.841,143.434,146.164,148.894,152.246,156.229,160.286,162.469,164.04399999999998,167.188,170.623,171.898,174.954,178.704,182.297,186.279,190.337,191.897,194.23,196.495,198.07,201.146,206.921,208.196,211.238,214.59,217.942,222.0,225.592,227.775,231.052,235.035,236.60999999999999,239.754,244.126,245.401,248.427,253.265,256.865,259.993,263.743,267.095,269.825,273.103,276.455,278.015,281.615,284.711,289.316" svgx:width="0.48,0.26,0.55,0.5,0.53,0.44,0.44,0.53,0.55,0.77,0.17,0.55,0.77,0.53,0.53,0.3,0.21,0.53,0.21,0.55,0.45,0.17,0.55,0.58,0.21,0.48,0.36,0.36,0.45,0.53,0.54,0.29,0.21,0.55,0.46,0.17,0.55,0.5,0.48,0.53,0.54,0.21,0.3,0.3,0.21,0.55,0.77,0.17,0.55,0.45,0.45,0.54,0.48,0.29,0.44,0.53,0.21,0.55,0.58,0.17,0.55,0.64,0.48,0.55,0.5,0.45,0.36,0.44,0.45,0.21,0.48,0.55,0.61,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">3) Rocco M, Montini L, Alessandri E, Venditti M, Laderchi A, De Pascale G,</text>
   <text y="293.33" x="68.485,72.235,75.588,79.645,83.627,87.61,89.185,91.445,96.05,97.325,99.609,103.359,104.919,107.184,110.536,112.096,115.696,117.921,123.696,124.971,127.218,130.968,132.528,136.121,138.386,140.568,144.551,148.608,151.961,155.943,157.503,159.07799999999997,161.404,165.154,166.429,168.661,173.033,177.015,179.28,183.263,187.245,190.838,192.398,193.958,195.533,197.801,203.576,204.851,207.098,210.848,212.408,215.138,218.288,220.534,222.484,225.837,229.114,231.379,235.362,237.544,240.244,242.531,244.481,248.463,250.638,252.905,256.258,259.535,263.435,265.775" svgx:width="0.5,0.45,0.54,0.53,0.53,0.21,0.55,0.61,0.17,0.55,0.5,0.21,0.3,0.45,0.21,0.48,0.55,0.77,0.17,0.55,0.5,0.21,0.48,0.3,0.29,0.53,0.54,0.45,0.53,0.21,0.21,0.55,0.5,0.17,0.55,0.58,0.53,0.3,0.53,0.53,0.48,0.21,0.21,0.21,0.55,0.77,0.17,0.55,0.5,0.21,0.36,0.42,0.55,0.26,0.45,0.44,0.3,0.53,0.29,0.36,0.55,0.26,0.53,0.29,0.55,0.45,0.44,0.52,0.3,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">Raponi G, Vitale M, Pietropaoli P, Antonelli M: Risk factors for acute</text>
   <text y="302.344" x="68.485,71.605,73.165,77.223,81.205,84.797,88.097,90.368,91.928,95.911,97.471,101.371,103.553,106.853,109.134,110.694,114.669,116.901,120.178,122.361,123.921,126.255,127.815,131.092,134.445,136.005,137.565,140.865,143.092,144.652,146.212,147.78699999999998,150.065,154.123,157.475,159.74,161.3,164.893,168.875,171.14,173.83999999999997,176.144,178.326,181.919,185.196,188.789,190.349,193.701,195.261,199.244,203.294,205.624,209.606,211.166,215.224,219.19899999999998,221.441,223.001,226.984,229.249,231.431,234.784,238.222,241.815,245.797,249.78,253.68,256.38,258.688,262.745,266.728,269.458,273.05,275.75,278.02,282.002" svgx:width="0.42,0.21,0.54,0.53,0.48,0.44,0.55,0.21,0.53,0.21,0.52,0.29,0.44,0.55,0.21,0.53,0.55,0.44,0.29,0.21,0.3,0.21,0.44,0.45,0.21,0.21,0.44,0.55,0.21,0.21,0.21,0.55,0.54,0.45,0.3,0.21,0.48,0.53,0.3,0.36,0.55,0.29,0.48,0.44,0.48,0.21,0.45,0.21,0.53,0.54,0.55,0.53,0.21,0.54,0.53,0.55,0.21,0.53,0.3,0.29,0.45,0.45,0.48,0.53,0.53,0.52,0.36,0.55,0.54,0.53,0.36,0.48,0.36,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">kidney injury in critically ill patients receiving high intravenous doses of</text>
   <text y="311.358" x="68.485,71.763,75.745,77.305,78.865,81.595,83.86,85.42,89.395,91.729,97.819,101.411,103.676,107.659,111.011,114.994,118.586,121.316,125.216,126.776,128.726,132.708,136.691,140.043,142.308,145.908,148.194,151.547,155.529,159.586,162.159,166.222,168.39700000000002,170.644,174.627,176.892,180.874,184.467,186.64200000000002,188.899,192.882,196.474,200.531,204.514,206.696,210.679,212.944,217.018,220.221,221.781,225.08100000000002,227.28,230.632,234.615,236.88,238.44,242.497,244.057,248.04,250.305,251.865,255.229,257.959,259.234,261.465" svgx:width="0.44,0.53,0.21,0.21,0.36,0.3,0.21,0.53,0.55,0.81,0.48,0.3,0.53,0.45,0.53,0.48,0.36,0.52,0.21,0.26,0.53,0.53,0.45,0.3,0.48,0.55,0.45,0.53,0.54,0.34,0.53,0.29,0.55,0.53,0.3,0.53,0.48,0.29,0.55,0.53,0.48,0.54,0.53,0.29,0.53,0.3,0.53,0.43,0.21,0.44,0.55,0.45,0.53,0.3,0.21,0.54,0.21,0.53,0.3,0.21,0.44,0.36,0.17,0.55,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">colistin methanesulfonate and/or other nephrotoxic antibiotics: a</text>
   <text y="320.315" x="68.485,70.668,74.26,76.525,78.708,82.69,85.42,89.477,93.07,96.434,98.699,100.259,103.612,107.21199999999999,109.474,112.751,116.734,120.716,124.698,126.881,129.131,131.414,134.144,136.409,140.309,144.366,147.644,148.919,151.199,155.414,157.597,159.157,161.422,162.982,166.259,169.612,171.18699999999998,173.423,176.7,180.053,182.235,185.835,188.106,190.056,193.409,197.391,201.374,205.511,209.493,213.475,214.75,216.962,220.397,224.38,228.437,229.997,233.349,237.332,241.389,243.339,245.649,249.241,252.833,256.426,260.018" svgx:width="0.29,0.48,0.3,0.29,0.53,0.36,0.54,0.48,0.44,0.3,0.21,0.45,0.48,0.55,0.44,0.53,0.53,0.53,0.29,0.3,0.55,0.36,0.3,0.52,0.54,0.44,0.17,0.55,0.56,0.29,0.21,0.3,0.21,0.44,0.45,0.21,0.55,0.44,0.45,0.29,0.48,0.55,0.26,0.45,0.53,0.53,0.54,0.53,0.53,0.17,0.55,0.46,0.53,0.54,0.21,0.45,0.53,0.54,0.26,0.55,0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">retrospective cohort study. Critical care (London, England) 2013,</text>
   <text y="329.329" x="68.485,72.078,75.67,77.62,81.212,83.162,84.407,88.157,91.75,95.342,98.935" svgx:width="0.48,0.48,0.26,0.48,0.26,0.17,0.5,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">17(4):R174.</text>
   <text y="353.31" x="56.523,61.099,65.515,69.931" svgx:width="0.57,0.55,0.55,0.55" style="fill:rgb(235,103,59);font-family:AdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;">P102</text>
   <text y="362.325" x="56.523,61.851,66.347,69.675,74.171,77.747,82.148,88.892,90.892,94.892,96.892,99.269,103.933,108.429,112.509,117.005,123.749,128.245,132.741,134.646,138.646,141.052,143.53199999999998,145.928,150.008,156.752,161.416,165.912,169.912,173.24,175.24,178.60000000000002,180.908,185.404,189.884,192.246,194.246,198.742,203.238,207.238,209.238,213.318,217.87800000000001,220.252,222.996,227.492,232.156,234.988,238.988,245.732,249.732,253.308,255.308" svgx:width="0.67,0.56,0.42,0.56,0.45,0.56,0.84,0.25,0.5,0.25,0.55,0.58,0.56,0.51,0.56,0.84,0.56,0.56,0.25,0.5,0.55,0.31,0.55,0.51,0.84,0.58,0.56,0.5,0.42,0.25,0.42,0.55,0.56,0.56,0.55,0.25,0.56,0.56,0.5,0.25,0.51,0.57,0.55,0.34,0.56,0.58,0.35,0.5,0.84,0.5,0.45,0.25,0.56" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Nosocomial pneumonia - emphasis on inhaled tobramycin</text>
   <text y="371.339" x="56.523,61.187,62.547,64.856,68.768,72.928,76.088,80.336,83.912,85.576,89.408" svgx:width="0.58,0.17,0.55,0.49,0.52,0.4,0.53,0.45,0.21,0.48,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">A. Kuzovlev</text>
   <text y="367.767" x="92.976" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="371.339" x="95.811,97.171,99.553,104.216,105.576,107.943,111.607,115.855,119.431,123.759,127.335,131.583,135.83" svgx:width="0.17,0.55,0.58,0.17,0.55,0.46,0.53,0.45,0.54,0.45,0.53,0.53,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, A. Shabanov</text>
   <text y="367.767" x="139.351" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="371.339" x="142.186,143.54600000000002,145.927,149.591,150.95100000000002,153.298,157.298,161.546,163.21,167.458,171.033,175.281,176.945,180.273,184.521" svgx:width="0.17,0.55,0.46,0.17,0.55,0.5,0.53,0.21,0.53,0.45,0.53,0.21,0.42,0.53,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, S. Polovnikov</text>
   <text y="367.767" x="188.05" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">3</text>
   <text y="371.339" x="190.942,192.30200000000002,194.626,198.626,199.98600000000002,202.337,208.497,212.745,215.073,219.321" svgx:width="0.17,0.55,0.5,0.17,0.55,0.77,0.53,0.29,0.53,0.4" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, V. Moroz</text>
   <text y="367.767" x="222.463" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="376.781" x="56.523" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="380.353" x="59.357,63.357,64.685,69.349,70.709,73.077,78.157,81.989,86.317,90.565,94.141,97.053,100.29,103.81,106.186,110.186,114.018,116.93,120.762,124.337,126.665,130.161,134.401,136.743,138.407,142.655,145.567,147.983,149.647,152.063,156.223,158.639,162.479,164.806,169.054,171.13400000000001,173.537,178.449,182.281,186.529,190.361,192.689,196.265,197.945,200.296,204.296,208.128,211.704,215.952,217.616,224.111,227.687,230.003,234.251,235.915,240.162,244.49,247.986,249.346,251.716,257.876,262.124,265.036,268.532,272.78,278.418" svgx:width="0.5,0.17,0.58,0.17,0.55,0.63,0.48,0.54,0.53,0.45,0.36,0.42,0.44,0.55,0.5,0.48,0.36,0.48,0.45,0.29,0.44,0.53,0.55,0.21,0.53,0.36,0.3,0.21,0.3,0.52,0.3,0.48,0.55,0.53,0.26,0.55,0.61,0.48,0.53,0.48,0.29,0.45,0.21,0.55,0.5,0.48,0.45,0.53,0.21,0.81,0.45,0.3,0.53,0.21,0.53,0.54,0.44,0.17,0.55,0.77,0.53,0.36,0.44,0.53,0.72,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">V.A. Negovsky Research Institute of General Reanimatology, Moscow,</text>
   <text y="389.31" x="56.523,60.523,64.683,67.595,70.507,72.171,75.747" svgx:width="0.5,0.52,0.36,0.36,0.21,0.45,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Russia;</text>
   <text y="385.795" x="79.427" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="389.31" x="82.261,87.341,88.669,92.669,94.029,96.378,100.042,103.37,105.034,106.698,108.778,113.026,115.938,120.186,122.266,125.178,128.506,132.026,134.362,136.026,140.274,143.186,145.602,147.266,149.682,153.842,156.258,160.098,162.425,166.673,168.75300000000001,171.156,174.82,181.316,185.148,187.476,191.804,195.534,199.782,203.278,206.798,209.197,215.357,219.189,223.517,225.181,228.677,230.341,234.483,238.315,239.675,242.079,248.239,252.487,255.399,258.895,263.143,268.781" svgx:width="0.63,0.17,0.5,0.17,0.55,0.46,0.42,0.21,0.21,0.26,0.53,0.36,0.53,0.26,0.36,0.42,0.44,0.55,0.21,0.53,0.36,0.3,0.21,0.3,0.52,0.3,0.48,0.55,0.53,0.26,0.55,0.46,0.81,0.48,0.29,0.54,0.48,0.53,0.44,0.44,0.55,0.77,0.48,0.54,0.21,0.44,0.21,0.53,0.48,0.17,0.55,0.77,0.53,0.36,0.44,0.53,0.72,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">N.V. Sklifosofsky Institute of Emergency Medicine, Moscow,</text>
   <text y="398.325" x="56.523,60.523,64.683,67.595,70.507,72.171,75.747" svgx:width="0.5,0.52,0.36,0.36,0.21,0.45,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Russia;</text>
   <text y="394.753" x="76.989" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">3</text>
   <text y="398.324" x="79.88,84.96,90.0,92.41,96.41,100.57,102.898,107.226,111.058,115.305,118.633,122.87299999999999,125.235,131.395,134.971,136.635,140.875,143.264,149.423,151.087,152.751,154.415,156.831,160.407,162.735,166.25500000000002,168.549,173.549,177.797,180.709,185.037,186.701,189.117,192.693,194.356,195.716,198.029,204.189,208.437,211.349,214.845,219.093,224.837,226.197,228.53,232.53,236.69,239.602,242.514,244.178" svgx:width="0.63,0.63,0.55,0.5,0.52,0.29,0.54,0.48,0.53,0.42,0.53,0.55,0.77,0.45,0.21,0.53,0.55,0.77,0.21,0.21,0.21,0.3,0.45,0.29,0.44,0.55,0.63,0.53,0.36,0.54,0.21,0.3,0.45,0.21,0.17,0.55,0.77,0.53,0.36,0.44,0.53,0.72,0.17,0.55,0.5,0.52,0.36,0.36,0.21,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">NN Burdenko Main Military Hospital, Moscow, Russia</text>
   <text y="407.339" x="56.523,60.558,62.694,64.191,66.402,67.9,70.985,74.785,76.38499999999999,78.519,82.555,86.355,88.554" svgx:width="0.53,0.28,0.2,0.29,0.2,0.41,0.5,0.2,0.55,0.53,0.5,0.28,0.42" style="fill:rgb(19,20,19);font-family:AdvTT1b53b5fb.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="407.339" x="93.997,97.637,101.277,104.918,108.558" svgx:width="0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">2016,</text>
   <text y="407.339" x="112.139,116.174,120.21,122.421,126.297,130.568,134.999,139.521,141.521,143.716,147.752,149.963" svgx:width="0.53,0.53,0.29,0.51,0.56,0.58,0.58,0.25,0.55,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">20(Suppl 2):</text>
   <text y="407.339" x="151.711,155.51,159.151,162.791" svgx:width="0.5,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">P102</text>
   <text y="425.31" x="56.523,58.603,63.099,65.843,68.675,73.171,77.747,82.148,85.724,88.468,90.468,94.964,99.46,102.788" svgx:width="0.26,0.56,0.34,0.35,0.56,0.57,0.56,0.45,0.34,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Introductions:</text>
   <text y="425.31" x="109.644,111.476,115.892,120.308,124.14,125.972,129.971,134.451,139.464,143.296,147.712,150.288,152.12,156.616,158.448,162.776,165.26,167.092,170.668,173.868,178.866,182.698,185.898,190.885,194.717,199.11700000000002,204.151,207.983,212.479,214.391,218.719,223.135,226.711,229.27100000000002,234.312,236.888,241.208,246.274,249.434,253.178,256.338,258.914,262.914,269.578,271.41,275.01000000000005,279.95,283.781,288.197" svgx:width="0.23,0.55,0.55,0.48,0.23,0.5,0.56,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4,0.55,0.48,0.4,0.55,0.48,0.55,0.55,0.48,0.56,0.24,0.54,0.55,0.45,0.32,0.55,0.32,0.54,0.55,0.4,0.47,0.4,0.32,0.5,0.83,0.23,0.45,0.55,0.48,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Inhaled antibiotics as an adjunct to systemic an-</text>
   <text y="434.325" x="56.523,59.099,60.931,65.427,67.259,71.587,74.163,75.995,79.483,82.683,86.06,90.556,93.132,97.132,100.292,104.292,108.708,111.268,114.69,118.522,121.72200000000001,125.065,128.905,132.322,135.482,137.314,141.73,146.146,147.978,150.306,152.138,155.714,159.545,163.961,166.52100000000002,169.909,172.485,175.061,179.061,182.893,185.469,192.133,196.045,200.461,203.02100000000002,206.477,213.141,217.469,221.965,225.797,227.629,229.461,232.037,235.797,239.132,240.964,245.364,248.769,250.601,255.177,260.29699999999997,263.736,268.232,272.064,274.64,276.472,280.472,284.888,287.464" svgx:width="0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4,0.55,0.56,0.32,0.5,0.4,0.5,0.55,0.32,0.55,0.48,0.4,0.55,0.48,0.55,0.4,0.23,0.55,0.55,0.23,0.29,0.23,0.45,0.48,0.55,0.32,0.55,0.32,0.32,0.5,0.48,0.32,0.83,0.5,0.55,0.32,0.55,0.83,0.54,0.56,0.48,0.23,0.23,0.32,0.47,0.55,0.23,0.55,0.55,0.23,0.57,0.64,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">tibiotics present as a significant treatment modality in ICU patients</text>
   <text y="443.339" x="56.523,62.355,64.187,66.763,71.16300000000001,73.531,77.947,82.274,85.434,89.762,93.338,97.666,104.33,106.162,109.994,111.834,114.18,118.676,123.092,127.092,131.419,138.083,142.411,146.827,148.659,152.499,154.829,157.077,162.325,166.573,168.821,170.421,172.801,176.712,181.128,185.128,187.54,191.372,193.204,199.844,202.28,206.608,208.928,211.351,213.927,218.343,220.175,223.375,225.751,228.911,231.487,235.815,240.311,244.071,246.444,252.276,256.107,259.307,261.637,264.213,268.533,270.991,272.823,277.239,281.071,285.071,288.231" svgx:width="0.73,0.23,0.32,0.55,0.55,0.55,0.54,0.4,0.54,0.45,0.54,0.83,0.23,0.48,0.23,0.55,0.56,0.55,0.5,0.54,0.83,0.54,0.55,0.23,0.48,0.55,0.28,0.66,0.53,0.28,0.2,0.55,0.49,0.55,0.5,0.55,0.48,0.23,0.83,0.55,0.54,0.29,0.55,0.32,0.55,0.23,0.4,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.73,0.48,0.4,0.55,0.32,0.54,0.55,0.23,0.55,0.48,0.5,0.4,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">with nosocomial pneumonia (NP). The aim of this study was to inves-</text>
   <text y="452.353" x="56.523,59.099,60.931,65.347,69.179,71.755,75.755,79.2,81.032,85.448,88.024,92.344,95.868,98.444,102.86,106.86,110.381,114.381,116.709,119.037,120.869,124.445,128.277,131.853,135.613,139.068,143.396,145.71599999999998,149.273,151.105,155.521,159.937,163.769,165.601,169.601,174.081,177.563,180.139,184.467,188.963,191.539,195.371,202.035,205.779,209.354,211.186,215.586,219.062,221.31,223.142,227.054,229.294,232.782,236.614,239.814,243.327,247.159,251.559,255.062,258.894,263.39,265.302,269.63,274.046,277.622,280.182,283.692,286.268" svgx:width="0.32,0.23,0.55,0.48,0.32,0.5,0.55,0.23,0.55,0.32,0.54,0.55,0.32,0.55,0.5,0.55,0.5,0.29,0.29,0.23,0.45,0.48,0.45,0.47,0.55,0.54,0.29,0.55,0.23,0.55,0.55,0.48,0.23,0.5,0.56,0.55,0.32,0.54,0.56,0.32,0.48,0.83,0.47,0.45,0.23,0.55,0.55,0.28,0.23,0.49,0.28,0.55,0.48,0.4,0.55,0.48,0.55,0.55,0.48,0.56,0.24,0.54,0.55,0.45,0.32,0.55,0.32,0.54" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">tigate into the efficacy of inhaled tobramycin (IT) as an adjunct to</text>
   <text y="461.311" x="56.523,59.683,63.427,66.587,69.163,73.163,79.827,81.658,85.258,87.534,91.366,95.782,98.357,100.189,104.685,106.517,110.845,113.421,115.253,118.829,122.029,124.328,126.16,130.56,133.002,135.578,139.994,143.994,146.325,148.901,151.477,155.477,159.309,161.885,168.549,172.549,176.965,179.525,181.872,186.2,188.51999999999998,190.943,196.191,200.431,202.791,204.623,209.023,211.409,214.569,218.569,223.065,226.225,228.057,231.217" svgx:width="0.4,0.47,0.4,0.32,0.5,0.83,0.23,0.45,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.32,0.32,0.5,0.48,0.32,0.83,0.5,0.55,0.32,0.55,0.54,0.29,0.55,0.66,0.53,0.55,0.23,0.55,0.55,0.4,0.5,0.56,0.4,0.23,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">systemic antibiotics in the treatment of NP in sepsis.</text>
   <text y="470.325" x="56.523,63.099,67.179,69.923,74.419,78.915,83.395,86.723" svgx:width="0.82,0.51,0.34,0.56,0.56,0.57,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Methods:</text>
   <text y="470.325" x="91.559,95.471,97.303,100.967,103.543,107.30300000000001,110.268,112.1,116.676,121.796,124.838,128.67,132.67,137.086,139.662,141.494,143.326,147.158,149.734,153.734,158.214,161.178,164.338,168.338,172.834,175.41,177.242,180.84199999999998,183.799,188.295,192.127,194.703,196.535,200.535,204.951,207.527,210.72699999999998,213.676,219.508,221.34,223.916,228.316,231.308,236.556,240.79600000000002,243.78,249.612,253.612,256.188,260.188,263.17,267.17,271.586,274.162,278.49,280.322,282.154,286.153" svgx:width="0.49,0.23,0.46,0.32,0.47,0.55,0.23,0.57,0.64,0.55,0.48,0.5,0.55,0.32,0.23,0.23,0.48,0.32,0.5,0.56,0.55,0.4,0.5,0.56,0.32,0.23,0.45,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55,0.55,0.66,0.53,0.55,0.73,0.5,0.32,0.5,0.55,0.5,0.55,0.32,0.54,0.23,0.23,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Sixty ICU ventilated septic patients with NP were enrolled</text>
   <text y="479.339" x="56.523,58.355,62.754999999999995,65.537,68.113,72.529,76.529,79.314,81.89,85.89,88.466,91.042,95.37,98.529,103.025,107.025,110.601,113.177,115.009,118.772,122.772,125.632,128.792,131.368,135.696,140.192,143.952,146.722,148.97,152.802,154.634,156.474,159.252,165.916,169.748,171.58,175.58,177.18,179.945,184.025,188.105,189.681,193.76100000000002,195.309,200.029,201.602,205.682,207.258,211.33800000000002,214.187,217.931,221.931,225.763,228.339,231.539,234.257,238.585,240.416,244.912,246.512,249.28,253.776,256.352,258.184,264.848,268.68,271.256,275.01599999999996,277.797,280.373,284.373,288.205" svgx:width="0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.32,0.5,0.32,0.32,0.54,0.4,0.56,0.5,0.45,0.32,0.23,0.48,0.5,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.28,0.48,0.23,0.23,0.55,0.83,0.48,0.23,0.5,0.2,0.55,0.51,0.51,0.2,0.51,0.55,0.59,0.55,0.51,0.2,0.51,0.55,0.47,0.5,0.48,0.32,0.4,0.55,0.54,0.23,0.56,0.2,0.55,0.56,0.32,0.23,0.83,0.48,0.32,0.47,0.55,0.32,0.5,0.48,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">in the retrospective study (all male, 58.4 ± 6.3 years old; primary rea-</text>
   <text y="488.353" x="56.523,59.683,64.011,68.411,72.794,75.122,79.45,82.01,86.457,88.289,92.865,97.985,102.444,105.604,108.18,112.012,115.772,120.132,122.53200000000001,126.992,128.823,133.239,135.815,138.391,142.223,146.055,150.551,155.047,159.375,165.94,167.772,172.188,176.02,177.86,182.268,184.1,188.516,190.843,194.843,198.419,200.995,202.827,207.155,211.571,214.771,219.118,221.366,225.446,229.526,233.915,240.243,242.491,244.091,248.485,255.149,259.149,263.645,265.477,269.309,272.469,275.045,276.775,281.191,283.023,285.599,287.431" svgx:width="0.4,0.54,0.55,0.55,0.29,0.54,0.32,0.55,0.23,0.57,0.64,0.55,0.4,0.32,0.48,0.47,0.55,0.3,0.55,0.23,0.55,0.32,0.32,0.48,0.48,0.56,0.56,0.54,0.83,0.23,0.55,0.48,0.23,0.55,0.23,0.55,0.29,0.5,0.45,0.32,0.23,0.54,0.55,0.4,0.55,0.28,0.51,0.51,0.55,0.79,0.28,0.2,0.55,0.83,0.5,0.56,0.23,0.48,0.4,0.32,0.23,0.55,0.23,0.32,0.23,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">son for ICU stay - intraabdominal infections (80 %), mediastinitis</text>
   <text y="497.311" x="56.523,58.771,62.851,66.931,70.753,77.081,79.329,80.92899999999999,84.699,89.027,91.603,96.019,100.019,102.57900000000001,106.413,108.661,112.741,116.56,122.888,125.136,127.384,128.984,132.831,138.079,139.911,143.743,148.159,152.575,156.903,160.063,161.895,165.095,168.775,173.103,175.423,179.32,184.568,188.80800000000002,192.586,198.418,202.25,205.45,209.254,215.918,219.749,224.245,228.245,232.045,235.876,239.452,243.028,247.356,249.932,254.428,256.26,260.676,265.07599999999996,268.895,271.471,275.791,279.61,282.186,286.602" svgx:width="0.28,0.51,0.51,0.55,0.79,0.28,0.2,0.55,0.54,0.32,0.55,0.5,0.32,0.55,0.28,0.51,0.55,0.79,0.28,0.28,0.2,0.55,0.66,0.23,0.48,0.55,0.55,0.54,0.4,0.23,0.4,0.55,0.54,0.29,0.55,0.66,0.53,0.55,0.73,0.48,0.4,0.55,0.83,0.48,0.56,0.5,0.55,0.48,0.45,0.45,0.54,0.32,0.56,0.23,0.55,0.55,0.55,0.32,0.54,0.55,0.32,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(13 %), other (9 %)). Diagnosis of NP was made according to the</text>
   <text y="506.325" x="56.523,59.683,62.259,66.091,70.507,75.003,78.835,81.41,85.89,91.219,94.795,96.627,98.459,102.875,104.707,108.283,112.115,113.955,119.225,123.057,127.473,131.953,137.311,141.887,146.135,147.966,151.886,157.266,160.842,163.418,165.25,167.826,171.826,174.402,176.234,180.066,181.666,186.973,191.805,194.965,198.125,202.453,206.029,207.861,211.693,214.186,216.018,220.346,224.762,227.962,233.291,237.619,239.939,245.31,251.974,256.302,258.134,260.71,262.542,265.118,269.118,272.278,274.11,277.27,279.779,283.611,288.027" svgx:width="0.4,0.32,0.48,0.55,0.56,0.48,0.32,0.56,0.55,0.45,0.23,0.23,0.55,0.23,0.45,0.48,0.23,0.55,0.48,0.55,0.56,0.55,0.57,0.53,0.23,0.49,0.55,0.45,0.32,0.23,0.32,0.5,0.32,0.23,0.48,0.2,0.55,0.6,0.4,0.4,0.54,0.45,0.23,0.48,0.32,0.23,0.54,0.55,0.4,0.55,0.54,0.29,0.55,0.83,0.54,0.23,0.32,0.23,0.32,0.5,0.4,0.23,0.4,0.32,0.48,0.55,0.32" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">standard clinical and CPIS criteria. Associations of multiresistant</text>
   <text y="515.339" x="56.523,60.939,63.515,67.347,74.011,76.427,80.73,84.73,89.146,92.978,95.554,97.386,101.218,105.218,109.247,113.743,117.575,121.151,123.727,127.727,130.303,132.135,135.975,139.975,142.223,145.382,149.382,153.798,156.958,158.79,161.366,163.198,167.03,171.03,175.011,177.587,181.90699999999998,185.952,188.528,192.856,197.352,199.928,203.76,210.424,214.168,217.744,219.576,223.992,226.232,230.229,236.061,240.061,242.637,246.637,250.639,255.135,259.135,261.711,265.711,269.286,271.862,275.862,280.34200000000004,284.371,286.203" svgx:width="0.55,0.32,0.48,0.83,0.3,0.55,0.5,0.55,0.48,0.32,0.23,0.48,0.5,0.55,0.56,0.48,0.45,0.32,0.5,0.32,0.23,0.48,0.55,0.28,0.4,0.5,0.55,0.4,0.23,0.32,0.23,0.48,0.5,0.55,0.32,0.54,0.55,0.32,0.54,0.56,0.32,0.48,0.83,0.47,0.45,0.23,0.55,0.28,0.55,0.73,0.5,0.32,0.5,0.55,0.56,0.5,0.32,0.5,0.45,0.32,0.5,0.56,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">gram-negative bacteria (sensitive to tobramycin) were detected in</text>
   <text y="524.354" x="56.523,61.019,63.595,67.923,72.339,75.915,80.331,84.658,88.384,90.216,94.048,98.048,102.376,104.208,108.04,110.60000000000001,113.952,115.784,119.616,123.448,127.28,131.696,135.696,138.954,141.202,145.53,150.362,154.106,156.346,159.703,164.031,166.351,169.681,173.513,175.345,177.185,180.51,185.006,188.838,191.414,193.246,197.246,201.662,204.238,207.398,208.998,212.258,216.506,220.338,222.914,224.746,228.746,233.162,235.738,238.938,242.192,248.024,252.024,254.6,258.6,261.922,264.498,268.33,272.746,277.242,281.57,288.233" svgx:width="0.56,0.32,0.54,0.55,0.45,0.55,0.54,0.48,0.23,0.48,0.5,0.54,0.23,0.48,0.32,0.55,0.23,0.48,0.48,0.48,0.55,0.5,0.55,0.28,0.54,0.6,0.47,0.28,0.55,0.54,0.29,0.55,0.48,0.23,0.23,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.2,0.55,0.53,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.32,0.48,0.55,0.56,0.54,0.83,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">bronchoalveolar lavage (BAL) of all patients. Patients were random-</text>
   <text y="533.311" x="56.523,58.355,61.771,65.771,70.251,72.68,74.512,78.928,81.504,85.82400000000001,88.327,90.903,96.735,101.055,103.521,107.937,110.513,114.84,119.168,123.664,126.824,128.424,130.847,132.679,136.599,139.067,141.315,145.715,147.288,152.008,153.581,157.661,161.741,163.989,165.589,168.037,171.869,176.365,180.861,182.693,185.269,187.101,191.429,195.829,198.311,202.639,204.959,207.439,209.271,213.19099999999997,215.66,218.236,222.55599999999998,225.014,228.174,231.918,235.078,237.654,241.654,248.318,250.15,253.75,256.195,260.027,264.443,267.019,268.851,273.347,275.179,279.507,282.083,283.915,287.491" svgx:width="0.23,0.43,0.5,0.56,0.55,0.23,0.55,0.32,0.54,0.55,0.32,0.73,0.54,0.55,0.55,0.32,0.54,0.54,0.56,0.4,0.2,0.55,0.23,0.49,0.55,0.28,0.55,0.55,0.59,0.55,0.51,0.51,0.28,0.2,0.55,0.48,0.56,0.56,0.23,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.23,0.49,0.55,0.32,0.54,0.55,0.4,0.47,0.4,0.32,0.5,0.83,0.23,0.45,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ized into two groups: IT (n = 30), addition of IT to systemic antibiotics</text>
   <text y="542.326" x="56.523,58.771,62.347,66.179,68.755,73.251,76.989,81.485,85.485,89.901,93.901,100.565,103.725,105.32499999999999,107.717,111.549,118.212,120.044,124.46,128.788,133.204,134.929,138.673,142.249,146.577,149.737,151.569,156.065,160.065,163.225,164.825,167.187,171.683,174.259,178.587,181.163,185.163,188.739,191.315,195.315,199.795,202.167,206.663,210.662,215.078,216.91,220.486,222.318,224.15,225.982,227.814,232.23,235.39,237.638,239.238,241.568,245.4,249.816,254.296,256.705,261.121,265.441,267.874,269.706,273.62600000000003,276.038,278.286,282.686,284.258" svgx:width="0.28,0.45,0.48,0.32,0.56,0.48,0.56,0.5,0.55,0.5,0.83,0.4,0.2,0.55,0.48,0.83,0.23,0.55,0.54,0.55,0.23,0.47,0.45,0.54,0.4,0.23,0.56,0.5,0.4,0.2,0.55,0.56,0.32,0.54,0.32,0.5,0.45,0.32,0.5,0.56,0.55,0.56,0.5,0.55,0.23,0.45,0.23,0.23,0.23,0.23,0.55,0.4,0.28,0.2,0.55,0.48,0.55,0.56,0.55,0.55,0.54,0.55,0.23,0.49,0.55,0.28,0.55,0.55,0.59" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(carbapenems, aminoglycosides, protected penicillins); and no IT (n =</text>
   <text y="551.34" x="56.523,60.603,64.683,66.931,68.53099999999999,71.036,74.196,78.612,80.444,82.772,85.33200000000001,87.93,92.258,94.57799999999999,97.228,100.388,104.132,107.292,109.868,113.868,120.532,122.364,125.964,128.466,132.298,136.714,139.29,141.122,145.618,147.45,151.778,154.354,156.186,159.761,162.96099999999998,165.429,169.261,172.837,176.413,180.741,183.317,187.813,189.645,194.061,198.461,201.033,203.609,207.929,210.558,213.718,217.718,222.133,225.293,227.125,229.701,231.533,235.276,237.108,239.684,243.428,245.028,247.635,252.795,255.371,259.699,264.027,268.522,271.722,274.224,280.056,284.056,286.632" svgx:width="0.51,0.51,0.28,0.2,0.55,0.4,0.55,0.23,0.29,0.32,0.55,0.54,0.29,0.55,0.4,0.47,0.4,0.32,0.5,0.83,0.23,0.45,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4,0.55,0.48,0.45,0.45,0.54,0.32,0.56,0.23,0.55,0.55,0.55,0.32,0.54,0.55,0.4,0.5,0.55,0.4,0.23,0.32,0.23,0.48,0.23,0.32,0.47,0.2,0.55,0.64,0.32,0.54,0.54,0.56,0.4,0.55,0.73,0.5,0.32,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">30), shift of systemic antibiotics according to sensitivity. Groups were</text>
   <text y="560.354" x="56.523,60.099,64.427,71.091,75.587,79.314,81.89,85.722,90.218,92.05,96.05,99.609,101.441,105.84100000000001,109.417,114.249,118.497,123.329,127.905,133.065,136.98499999999999,140.428,142.26,144.1,147.685,151.517,155.933,160.41299999999998,163.956,168.532,172.78,174.612,178.53199999999998,182.041,185.201,188.777,193.105,195.681,199.681,202.841,204.441,207.95,209.782,214.198,218.614,222.445,224.277,228.277,232.75699999999998,236.24,238.816,243.144,247.64,250.216,254.048,260.711,264.455,268.031,269.863,274.263,277.796,283.628,287.46" svgx:width="0.45,0.54,0.83,0.56,0.48,0.32,0.48,0.56,0.23,0.5,0.55,0.23,0.55,0.55,0.6,0.53,0.6,0.57,0.64,0.49,0.55,0.23,0.23,0.55,0.48,0.55,0.56,0.55,0.57,0.53,0.23,0.49,0.55,0.4,0.45,0.54,0.32,0.5,0.4,0.2,0.55,0.23,0.55,0.55,0.48,0.23,0.5,0.56,0.55,0.32,0.54,0.56,0.32,0.48,0.83,0.47,0.45,0.23,0.55,0.55,0.73,0.48,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">comparable in APACHE II and CPIS scores. Inhaled tobramycin was</text>
   <text y="569.312" x="56.523,60.355,64.851,71.515,73.347,77.763,79.483,82.643,85.219,89.219,91.795,95.795,100.275,103.068,107.148,111.228,115.30799999999999,118.092,124.756,129.156,131.981,134.557,140.389,142.221,145.797,149.797,152.561,157.057,160.889,162.721,164.553,168.313,171.1,174.932,176.764,180.604,183.345,187.761,191.761,196.257,200.585,202.417,204.249,207.665,211.665,214.241,215.841,218.608,223.856,228.096,230.853,233.429,237.429,240.589,244.917,246.749,251.077,253.653,255.485,259.813,264.21299999999997,267.023,271.351,275.751,278.532,283.028,286.86" svgx:width="0.48,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.5,0.32,0.5,0.56,0.55,0.51,0.51,0.51,0.55,0.83,0.55,0.55,0.32,0.73,0.23,0.45,0.5,0.55,0.56,0.48,0.23,0.23,0.47,0.55,0.48,0.23,0.48,0.55,0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.2,0.55,0.66,0.53,0.55,0.32,0.5,0.4,0.54,0.23,0.54,0.32,0.23,0.54,0.55,0.55,0.54,0.55,0.55,0.56,0.48,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">administered 300 mg twice daily via nebulizer. NP resolution on day</text>
   <text y="578.326" x="56.523,60.603,64.459,68.291,70.619,73.195,77.195,79.755,83.678,85.51,89.43,93.316,95.148,99.564,101.396,103.972,105.804,109.636,112.212,114.044,118.372,122.772,126.652,132.483,136.315,139.515,143.376,147.208,150.368,153.528,157.528,160.688,163.848,167.848,172.328,176.201,180.033,183.23299999999998,187.086,190.92600000000002,194.853,199.349,201.925,203.757,210.421,214.253,216.829,220.589,224.447,228.775,233.103,235.679,239.255,243.583,250.247,254.154,255.754,259.653,263.565,267.981,271.981,275.867,280.363,284.195,286.771" svgx:width="0.51,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.23,0.49,0.55,0.23,0.55,0.23,0.32,0.23,0.48,0.32,0.23,0.54,0.55,0.55,0.73,0.48,0.4,0.55,0.48,0.4,0.4,0.5,0.4,0.4,0.5,0.56,0.55,0.48,0.4,0.55,0.48,0.55,0.56,0.32,0.23,0.83,0.48,0.32,0.47,0.55,0.54,0.54,0.32,0.45,0.54,0.83,0.5,0.2,0.55,0.49,0.55,0.5,0.55,0.56,0.48,0.32,0.48" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">5 after IT initiation was assessed as a primary outcome. The data</text>
   <text y="587.34" x="56.523,62.355,66.355,68.931,72.931,76.592,79.752,82.328,86.16,88.736,90.568,93.728,96.304,98.136,101.712,105.544,107.376,109.208,112.968,116.674,120.506,124.922,128.754,130.586,134.33,137.746,141.746,146.226,149.896,154.392,158.152,161.858,165.77,169.682,174.514,178.426,180.258,184.17,188.082,189.914,194.49,199.29000000000002,203.018,207.098,208.674,212.75400000000002,216.454,218.702,225.118,226.718,230.457,235.289,239.201,243.28,247.36,251.44,253.016,254.61599999999999,258.293,263.541,267.541,273.373,280.037,283.869,288.17" svgx:width="0.73,0.5,0.32,0.5,0.55,0.4,0.32,0.48,0.32,0.23,0.4,0.32,0.23,0.45,0.48,0.23,0.23,0.47,0.55,0.48,0.55,0.48,0.23,0.47,0.43,0.5,0.56,0.55,0.56,0.47,0.55,0.49,0.49,0.6,0.49,0.23,0.49,0.49,0.23,0.57,0.6,0.55,0.51,0.2,0.51,0.55,0.28,0.8,0.2,0.55,0.6,0.49,0.51,0.51,0.51,0.2,0.2,0.55,0.66,0.5,0.73,0.83,0.48,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">were statistically analyzed by STATISTICA 7.0 (M, &amp;#963;, Newman-</text>
   <text y="596.354" x="56.523,60.851,64.851,69.179,71.011,74.211,76.535,79.111,83.111,86.271,88.847,90.44699999999999,92.806,97.286,98.873,103.593,105.165,109.245,110.821,114.901,118.981,121.229" svgx:width="0.54,0.5,0.54,0.23,0.4,0.55,0.32,0.5,0.4,0.32,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.28,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Keuls test; p &lt; 0.05).</text>
   <text y="605.312" x="56.523,61.019,65.099,68.427,72.923,74.923,77.667,80.901" svgx:width="0.56,0.51,0.42,0.56,0.25,0.34,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Results:</text>
   <text y="605.312" x="85.776,90.482,94.847,101.511,103.181,107.597,109.19,112.35,114.746,117.322,120.982,123.558,125.177,129.505,133.905,136.515,140.843,143.16299999999998,145.756,147.457,151.37699999999998,154.034,157.866,161.066,163.615,167.447,171.847,174.444,178.128,182.624,184.364,188.692,192.925,196.383,198.943,201.656,204.232,208.552,211.124,214.284,217.814,220.973,223.369,227.369,233.857,235.558,239.158,241.794,245.626,249.844,252.42,254.096,258.462,260.294,264.471,266.909,268.741,272.125,275.325,277.964,283.796,287.432" svgx:width="0.6,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.23,0.49,0.55,0.48,0.4,0.55,0.48,0.55,0.55,0.48,0.56,0.24,0.54,0.55,0.45,0.32,0.55,0.32,0.54,0.55,0.4,0.47,0.4,0.32,0.5,0.83,0.23,0.45,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4,0.55,0.73,0.48,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Administration of IT as an adjunct to systemic antibiotics was</text>
   <text y="614.326" x="56.523,60.208,63.368,66.387,70.583,74.159,75.799,79.631,82.034,86.034,90.51400000000001,92.579,98.411,100.006,102.582,106.982,109.077,112.917,115.03,119.446,121.096,125.512,129.714,133.714,136.274,138.331,140.163,144.398,147.974,149.614,154.11,157.891,162.307,165.715,169.715,171.838,176.166,178.486,180.568,185.816,190.056,192.077,194.653,198.483,201.643,205.797,207.498,211.826,214.244,215.945,220.273,224.673,226.773,229.021,232.897,236.977,239.133,245.453,247.58,251.412,254.383,255.983,258.124,262.093,266.173,268.329,274.657,276.257,278.307,282.78700000000003,284.26" svgx:width="0.48,0.4,0.4,0.54,0.45,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.48,0.55,0.55,0.23,0.55,0.55,0.5,0.32,0.55,0.23,0.55,0.45,0.23,0.56,0.5,0.55,0.45,0.5,0.55,0.54,0.29,0.55,0.66,0.53,0.55,0.32,0.5,0.4,0.54,0.23,0.54,0.32,0.23,0.54,0.55,0.55,0.28,0.51,0.51,0.55,0.79,0.55,0.48,0.4,0.2,0.55,0.51,0.51,0.55,0.79,0.2,0.55,0.56,0.55,0.59" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">associated with a higher incidence of NP resolution (84 % vs. 52 %, p =</text>
   <text y="623.34" x="56.523,60.492,62.068,65.934,69.903,73.983,77.896,79.496,82.148,85.74799999999999,88.441,91.899,94.475,96.151,98.727,102.501,105.077,106.753,110.948,115.364,117.411,119.011,121.72,125.518,129.934,133.934,136.516,141.012,144.794,148.37,150.803,154.658,158.49,161.462,165.462,168.151,172.479,174.799,177.449,183.968,185.8,189.184,191.76,195.931,200.296,202.128,205.795,207.635,210.274,212.85,214.526,217.102,220.932,223.492,226.205,228.642,232.962,235.672,239.641,243.72,247.8,250.412,252.988,257.308,259.937,263.906,267.875,271.955,274.621,279.197,282.842,287.887" svgx:width="0.51,0.2,0.51,0.51,0.51,0.51,0.2,0.55,0.45,0.55,0.45,0.32,0.23,0.32,0.5,0.32,0.23,0.54,0.55,0.28,0.2,0.55,0.49,0.55,0.5,0.55,0.56,0.5,0.45,0.32,0.5,0.48,0.4,0.5,0.55,0.54,0.29,0.55,0.83,0.23,0.45,0.32,0.54,0.56,0.23,0.48,0.23,0.55,0.32,0.23,0.32,0.5,0.32,0.55,0.32,0.54,0.55,0.51,0.51,0.51,0.55,0.32,0.54,0.55,0.51,0.51,0.51,0.55,0.57,0.48,0.64,0.33" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">0,0322, χ criterion). The decrease of microbial titer to 103 to 104 CFU/</text>
   <text y="632.355" x="56.523,63.043,64.883,67.691,73.523,77.159,80.35900000000001,83.112,87.478,91.478,93.884,97.884,101.254,103.83,107.661,112.141,114.917,116.749,121.149,123.875,128.371,132.492,135.068,139.46800000000002,142.187,146.602,148.99,153.318,157.494,161.859,165.059,167.812,172.308,176.06799999999998,178.753,183.249,186.917,190.545,193.74499999999998,196.498,200.578,203.415,205.852,210.172,212.995,216.964,218.564,221.386,225.752,230.08,232.64000000000001,235.389,237.09,239.65,242.476,248.308,251.944,255.14399999999998,257.896,260.472,264.303,266.135,267.761,271.593,275.925,277.626,281.626,284.429,286.261" svgx:width="0.83,0.23,0.55,0.73,0.48,0.4,0.55,0.56,0.5,0.32,0.5,0.45,0.32,0.5,0.56,0.55,0.23,0.55,0.55,0.56,0.54,0.32,0.55,0.55,0.55,0.32,0.54,0.54,0.56,0.4,0.55,0.56,0.47,0.55,0.56,0.48,0.47,0.4,0.55,0.51,0.55,0.32,0.54,0.55,0.51,0.2,0.55,0.56,0.54,0.32,0.55,0.23,0.32,0.55,0.73,0.48,0.4,0.55,0.32,0.5,0.23,0.23,0.48,0.56,0.23,0.5,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ml was detected in both groups by days 5 to 7, but it was reliable in</text>
   <text y="641.312" x="56.523,60.492,64.46,66.036,70.116,72.511,78.83099999999999,81.298,85.626,87.946,90.369,92.945,97.172,101.172,103.635,108.131,111.799,114.375,115.994,119.994,124.215,126.791,129.99099999999999,132.379,136.574,138.894,141.393,145.809,148.196,152.524,156.7,161.17999999999998,163.673,167.75300000000001,170.25,172.498,176.97799999999998,178.357,183.077,184.593,188.562,190.138,194.004,198.084,200.183,201.783,204.209,208.121,210.558,214.243,218.739,220.423,223.881,227.713,230.117,231.818,236.146,240.546,242.987,247.182,249.50199999999998,252.001,258.665,260.335,263.793,266.369,270.483,274.978,278.816,282.01599999999996,284.429,286.261" svgx:width="0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.54,0.29,0.55,0.32,0.55,0.5,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.54,0.29,0.55,0.55,0.32,0.54,0.54,0.56,0.55,0.51,0.55,0.28,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.28,0.2,0.55,0.49,0.32,0.48,0.56,0.23,0.45,0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.83,0.23,0.45,0.32,0.54,0.56,0.5,0.4,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">73,6 % of the patients of group 1 (p &lt; 0.02). Eradication of microbes in</text>
   <text y="650.327" x="56.523,60.718,65.55,69.31,71.659,75.987,80.387,82.771,87.267,90.935,94.69500000000001,97.171,101.251,103.691,109.523,113.159,116.35900000000001,118.828,122.513,126.089,130.337,132.169,135.95,139.782,143.603,148.083,150.577,152.409,156.809,159.194,163.163,167.24300000000002,169.74,176.06,178.527,182.855,185.17499999999998,187.598,189.299,193.211,195.479,197.916,200.492,204.323,208.155,210.559,214.414,218.89399999999998,221.387,225.883,229.551,232.127,233.746,237.746,241.967,244.543,247.743,250.074,253.906,258.124,262.60400000000004,265.098,266.93,271.33,273.715,277.795,281.875,284.26" svgx:width="0.54,0.6,0.47,0.55,0.54,0.55,0.55,0.56,0.48,0.47,0.55,0.51,0.55,0.73,0.48,0.4,0.55,0.48,0.45,0.55,0.23,0.5,0.48,0.5,0.56,0.55,0.23,0.55,0.55,0.51,0.51,0.55,0.79,0.55,0.54,0.29,0.55,0.23,0.49,0.3,0.32,0.32,0.5,0.48,0.32,0.5,0.56,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.48,0.55,0.56,0.55,0.23,0.55,0.55,0.51,0.51,0.55,0.79" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">BAL on day 7 was achieved in 72 % of IT-treated patients and in 48 %</text>
   <text y="659.341" x="56.523,60.718,63.038000000000004,65.537,69.369,73.587,76.163,77.839,82.205,84.037,88.214,90.652,92.484,96.08399999999999,98.476,101.636,105.846,107.678,109.872,112.432,114.917,119.413,123.081,125.519,127.351,131.188,135.604,137.991,141.151,142.751,145.134,148.933,151.509,155.339,159.171,161.519,168.183,172.007,176.423,178.983,181.361,187.193,188.844,191.42,195.82,198.255,199.956,203.87599999999998,206.419,212.939,216.771,221.103,225.103,227.566,229.398,231.958,234.369,238.865,243.044,246.204,249.167,250.868,255.363,257.047,261.047,263.511,266.087,270.407,272.865,278.534,282.534,286.188" svgx:width="0.54,0.29,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.55,0.4,0.55,0.23,0.29,0.32,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.2,0.55,0.49,0.32,0.5,0.48,0.32,0.83,0.5,0.55,0.32,0.55,0.73,0.23,0.32,0.55,0.55,0.23,0.49,0.55,0.83,0.48,0.56,0.5,0.55,0.23,0.32,0.55,0.56,0.54,0.4,0.4,0.23,0.56,0.23,0.5,0.55,0.32,0.54,0.55,0.73,0.5,0.48,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">of antibiotic shift patients. Treatment with IT made it possible to wean</text>
   <text y="668.355" x="56.523,60.888,64.72,67.124,68.825,72.825,77.046,79.622,82.822,85.606,89.462,93.294,95.698,97.529,99.156,103.156,105.562,107.16199999999999,110.041,114.406,118.16600000000001,121.039,125.535,129.203,132.963,135.835,139.804,141.38,145.46,146.834,151.554,153.07,157.038,158.614,162.69400000000002,165.485,169.317,172.289,173.88899999999998,176.767,180.736,184.704,186.28,190.36,191.791,196.511,197.97,202.05,203.469,207.549,210.442,212.143,216.543,219.457,222.033,226.26,230.26,233.12,237.448,239.866,244.282,248.03,250.59,253.529,257.945,260.332,264.527,268.855,273.33500000000004,276.15,278.398,282.87800000000004,284.257" svgx:width="0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.5,0.48,0.32,0.23,0.23,0.5,0.32,0.2,0.55,0.56,0.47,0.55,0.56,0.48,0.47,0.55,0.51,0.2,0.51,0.55,0.59,0.55,0.51,0.2,0.51,0.55,0.48,0.4,0.2,0.55,0.51,0.51,0.2,0.51,0.55,0.59,0.55,0.51,0.2,0.51,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.54,0.32,0.55,0.5,0.32,0.55,0.55,0.32,0.54,0.54,0.56,0.55,0.28,0.56,0.55,0.59" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">patients earlier: by day 8.2 ± 1.5 vs. 11.1 ± 2.8 in the other group (p =</text>
   <text y="677.313" x="56.523,60.492,62.068,65.934,69.903,73.983,76.082,77.68199999999999,80.56,85.72,89.518,93.35,95.754,97.585,101.82,106.22,109.19,110.891,115.219,118.204,121.404,124.328,128.012,132.428,136.908,139.804,142.242,144.074,148.308,152.724,154.374,156.95,161.064,164.26399999999998,167.187,173.019,176.824,179.4,183.4,186.236,190.601,194.601,197.007,201.007,204.378,206.954,210.784,215.26399999999998,218.211,222.539,226.772,228.473,232.233,235.162,236.994,241.394,244.29,246.728,251.144,253.531,257.531,261.531,264.359,268.855,272.523,275.099,276.718,280.718,284.939,287.515" svgx:width="0.51,0.2,0.51,0.51,0.51,0.28,0.2,0.55,0.64,0.5,0.48,0.32,0.23,0.55,0.55,0.55,0.23,0.54,0.4,0.4,0.55,0.48,0.55,0.56,0.55,0.32,0.23,0.55,0.55,0.23,0.32,0.54,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.56,0.5,0.32,0.5,0.45,0.32,0.5,0.56,0.55,0.54,0.55,0.23,0.47,0.55,0.23,0.55,0.55,0.32,0.55,0.32,0.5,0.5,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">0.001). Hearing loss and tinnitus were detected only in three patients</text>
   <text y="686.327" x="56.523,58.96,61.536,65.367,69.199,71.603,75.458,79.938,83.338,89.17,90.821,93.397,97.79700000000001,101.082,102.914,106.638,108.238,111.627,115.425,119.841,123.646,126.084,130.084,133.511,139.343,143.092,145.668,149.668,152.957,157.373,161.69299999999998,164.976,168.552,172.176,175.336,179.149,182.349,185.726,189.921,192.24099999999999,195.647,200.143,202.507,206.835,211.068,214.644,218.892,223.087,226.247,230.57,234.402,237.373,244.01299999999998,247.408,251.773,256.101,258.519,260.22,264.636,269.036,272.352,274.053,278.469,282.727,286.412,288.244" svgx:width="0.32,0.32,0.5,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.23,0.49,0.2,0.55,0.49,0.55,0.5,0.32,0.5,0.55,0.73,0.5,0.32,0.5,0.55,0.55,0.54,0.55,0.45,0.48,0.4,0.5,0.4,0.55,0.54,0.29,0.55,0.56,0.32,0.54,0.55,0.45,0.55,0.54,0.4,0.56,0.48,0.4,0.83,0.55,0.56,0.54,0.32,0.23,0.55,0.55,0.55,0.23,0.55,0.55,0.48,0.23,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">treated with IT. There were no cases of bronchospasm during inhal-</text>
   <text y="695.341" x="56.523,60.208,62.784,64.46,68.655,73.055,75.344,79.539,81.859,84.131,85.832,89.744,91.344,93.486,97.284,101.7,105.7,107.829,114.492,118.657,121.095,123.671,127.331,129.163,130.789,133.365,137.125,139.293,141.731,145.563,147.966,151.966,155.166,157.264,161.76,163.387,167.867,170.133,174.549,178.694,181.254,183.513,187.879,189.711,191.848,194.175,197.971,200.531,202.79,207.286,211.123,213.561,219.393,223.198,227.198,231.598,233.743,236.319,240.546,244.546,246.782,251.198,253.585,257.78,262.108,266.398,269.598,271.84,274.088,277.963,282.043,284.256" svgx:width="0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.23,0.49,0.2,0.55,0.49,0.55,0.5,0.55,0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.55,0.32,0.48,0.32,0.5,0.4,0.55,0.56,0.23,0.56,0.55,0.55,0.54,0.32,0.55,0.56,0.23,0.29,0.29,0.5,0.32,0.55,0.56,0.5,0.32,0.73,0.5,0.5,0.55,0.55,0.32,0.55,0.5,0.55,0.55,0.32,0.54,0.54,0.56,0.4,0.55,0.28,0.51,0.51,0.55,0.79" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ation of IT. The mortality rates did not differ between the groups (16 %</text>
   <text y="704.355" x="56.523,58.224,62.623999999999995,64.687,66.519,70.243,72.659,76.875,79.451,83.622,87.817,92.297,94.394,98.225,101.197,102.797,104.825,108.793,112.873,114.972,121.292,123.363,125.064,129.464,131.527,135.359,139.577,142.153,143.829,148.194,150.026,154.147,156.723,158.399,161.999,164.012,167.172,171.439,173.14,175.468,178.028,180.056,184.472,186.86,191.055,195.383,199.672,201.92" svgx:width="0.23,0.55,0.55,0.23,0.49,0.3,0.55,0.32,0.54,0.54,0.56,0.55,0.48,0.4,0.2,0.55,0.51,0.51,0.55,0.79,0.55,0.23,0.55,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.55,0.4,0.55,0.23,0.29,0.32,0.55,0.55,0.32,0.54,0.54,0.56,0.28,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">in IT-group vs. 12 % in antibiotic shift group).</text>
   <text y="713.313" x="56.523,61.187,65.683,70.179,73.755,75.755,80.251,83.578,85.578,89.972,94.468,97.796" svgx:width="0.58,0.56,0.56,0.45,0.25,0.56,0.42,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Conclusions:</text>
   <text y="713.313" x="102.444,107.149,111.645,118.091,119.923,124.157,125.989,128.976,131.552,133.965,137.65,140.226,141.902,146.097,150.497,153.014,157.342,159.662,162.085,163.785,167.70499999999998,170.192,174.024,177.224,179.603,183.435,187.835,190.204,194.036,198.368,200.28,204.378,208.794,212.202,214.762,217.247,219.823,224.143,226.602,229.761,233.291,236.451,238.847,242.847,249.278,251.11,254.71,257.102,260.934,265.152,267.728,269.347,273.843,275.47,279.798,282.217,284.049,287.433" svgx:width="0.6,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.23,0.49,0.55,0.48,0.4,0.55,0.48,0.55,0.55,0.48,0.56,0.24,0.54,0.55,0.45,0.32,0.55,0.32,0.54,0.55,0.4,0.47,0.4,0.32,0.5,0.83,0.23,0.45,0.55,0.48,0.55,0.32,0.23,0.56,0.23,0.54,0.32,0.23,0.45,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Administration of IT as an adjunct to systemic antibiotics</text>
   <text y="722.327" x="56.523,58.224,61.424,63.666,67.521,69.849,71.999,73.831,77.215,79.047,82.885,87.301,89.861,92.013,93.845,98.245,100.403,102.979,107.206,111.206,113.442,116.018,118.431,122.431,126.028,128.604,135.099,139.099,143.319,145.879,148.138,152.334,154.654,156.926,162.174,166.41400000000002,168.548,172.548,174.841,176.541,179.101,181.36,183.192,187.03,190.862,195.137,198.337,200.579,203.017,207.337,209.594,213.434,215.717,220.133,221.726,226.142,230.344,234.344,236.904,239.075,241.651,245.311,247.887,251.887,254.042,258.37,260.69,262.829,268.077,272.317,274.508,277.084,280.858,284.018,288.171" svgx:width="0.23,0.4,0.55,0.5,0.29,0.29,0.23,0.45,0.23,0.5,0.55,0.32,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.32,0.32,0.5,0.48,0.32,0.83,0.5,0.55,0.32,0.55,0.54,0.29,0.55,0.66,0.53,0.55,0.5,0.55,0.23,0.32,0.55,0.23,0.5,0.48,0.56,0.4,0.55,0.32,0.54,0.55,0.48,0.55,0.55,0.23,0.55,0.55,0.5,0.32,0.55,0.32,0.48,0.32,0.5,0.55,0.54,0.29,0.55,0.66,0.53,0.55,0.32,0.5,0.4,0.54,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">is efficient in the treatment of NP – it leads to a higher rate of NP reso-</text>
   <text y="731.342" x="56.523,58.224,62.552,64.97,66.671,70.999,75.399,77.386,81.218,85.436,89.91600000000001,92.013,95.698,100.098,102.217,106.073,109.905,112.309,114.14,115.767,119.767,122.327,124.328,130.159,133.965,137.65,142.066,143.716,148.132,152.532,154.488,156.816,159.25,163.445,170.08499999999998,172.176,176.008,179.829,184.245,186.576,188.408,190.091,193.923,196.27,200.598,203.016" svgx:width="0.23,0.54,0.32,0.23,0.54,0.55,0.55,0.48,0.55,0.56,0.55,0.48,0.55,0.55,0.5,0.48,0.32,0.23,0.23,0.5,0.32,0.55,0.73,0.5,0.48,0.55,0.23,0.55,0.55,0.55,0.29,0.32,0.54,0.83,0.55,0.48,0.5,0.55,0.32,0.23,0.23,0.48,0.32,0.54,0.32,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">lution and an earlier weaning from ventilator.</text>
   <text y="95.363" x="304.78,309.356,313.772,318.188" svgx:width="0.57,0.55,0.55,0.55" style="fill:rgb(235,103,59);font-family:AdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;">P103</text>
   <text y="104.321" x="304.78,306.86,311.34000000000003,313.737,317.737,319.737,322.481,325.313,329.793,332.163,336.242,340.242,344.242,346.242,350.738,354.738,357.482,359.482,363.978,368.458,370.77,375.266,377.74600000000004,380.181,384.181,390.925,392.925,396.925,400.818,404.394,406.393,410.873,413.29,415.29,419.786,424.282,428.282,430.282,434.36199999999997,436.704,440.704,445.2,449.76,452.125,455.701,460.197,466.941,473.685,477.765,480.597,484.173,486.173,490.172,492.172,494.532,499.028,503.107,507.771,512.267,514.267,516.267,519.843,523.923,526.755,530.115,532.402,534.402" svgx:width="0.26,0.56,0.55,0.5,0.25,0.34,0.35,0.56,0.55,0.51,0.5,0.5,0.25,0.56,0.5,0.34,0.25,0.56,0.56,0.55,0.56,0.31,0.55,0.5,0.84,0.25,0.5,0.5,0.45,0.25,0.56,0.55,0.25,0.56,0.56,0.5,0.25,0.51,0.55,0.5,0.56,0.57,0.55,0.45,0.56,0.84,0.84,0.51,0.35,0.45,0.25,0.5,0.25,0.55,0.56,0.51,0.58,0.56,0.25,0.25,0.45,0.51,0.35,0.42,0.55,0.25,0.56" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">In vitro evaluation of amikacin inhale and commercial nebulizers in</text>
   <text y="113.335" x="304.78,308.78,311.129,317.873,321.953,325.529,330.025,334.025,338.521,340.521,344.097,348.097,350.097,352.458,356.458,360.538,365.034,367.778,369.778,371.677,375.677,378.421,382.917" svgx:width="0.5,0.55,0.84,0.51,0.45,0.56,0.5,0.56,0.25,0.45,0.5,0.25,0.55,0.5,0.51,0.56,0.34,0.25,0.25,0.5,0.34,0.56,0.35" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">a mechanical ventilator</text>
   <text y="122.349" x="304.78,309.86,311.22,313.567,317.479,321.055,325.383,327.711,329.375,332.871,337.118" svgx:width="0.63,0.17,0.55,0.49,0.45,0.54,0.29,0.21,0.44,0.53,0.52" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">N. Kadrichu</text>
   <text y="118.772" x="341.235" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="122.343" x="344.126,345.486,347.811,351.475,352.83500000000004,355.238,360.398,363.974,368.222" svgx:width="0.17,0.55,0.46,0.17,0.55,0.64,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, T. Dang</text>
   <text y="118.772" x="372.472" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="122.343" x="375.364,376.724,379.105,383.017,384.377,386.702,391.198,395.446,397.774,401.102,404.934,407.262" svgx:width="0.17,0.55,0.49,0.17,0.55,0.56,0.53,0.29,0.42,0.48,0.29,0.44" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, K. Corkery</text>
   <text y="118.772" x="410.74" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="122.343" x="413.631,414.991,417.316,421.316,422.676,425.026,429.522,433.77,437.346,439.01,440.674,444.922,449.17,453.002" svgx:width="0.17,0.55,0.5,0.17,0.55,0.56,0.53,0.45,0.21,0.21,0.53,0.53,0.48,0.29" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, P. Challoner</text>
   <text y="118.772" x="455.301" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="127.786" x="304.781" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="131.358" x="307.616,312.696,316.944,320.52,324.095,326.423,328.839,330.503,333.383,335.792,339.792,344.04,347.616,349.944,356.44,360.016,363.512,367.257,371.416,373.832,375.496,378.992,382.568,384.232,387.144,388.504,390.841,394.505,398.081,402.321,404.73,409.226,412.802,415.13,416.794,421.042,423.954,425.314,427.634,432.634,436.298,440.962" svgx:width="0.63,0.53,0.45,0.45,0.29,0.3,0.21,0.36,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.45,0.21,0.36,0.17,0.55,0.46,0.45,0.53,0.55,0.56,0.45,0.29,0.21,0.53,0.36,0.17,0.55,0.63,0.46,0.58,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Novartis Pharmaceuticals, San Carlos, USA;</text>
   <text y="127.786" x="444.642" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="131.358" x="447.534,452.614,456.446,459.774,462.19,465.766,468.086,470.438,474.101,478.349,482.181,484.509,488.085,492.413,496.245,500.405,502.821,504.396,507.892,510.804,512.164,514.544,518.208,521.784" svgx:width="0.63,0.48,0.42,0.3,0.45,0.29,0.55,0.46,0.53,0.48,0.29,0.45,0.54,0.48,0.52,0.3,0.21,0.44,0.36,0.17,0.55,0.46,0.45,0.53" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Nektar Therapeutics, San</text>
   <text y="140.315" x="304.782,308.446,310.774,314.35,318.598,322.094,323.758,326.67,330.166,334.319,335.67900000000003,338.061,342.557,347.221,348.581,350.93,355.93,359.594" svgx:width="0.46,0.29,0.45,0.53,0.44,0.21,0.36,0.44,0.53,0.17,0.55,0.56,0.58,0.17,0.55,0.63,0.46,0.58" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Francisco, CA, USA</text>
   <text y="149.329" x="304.781,308.816,310.952,312.449,314.661,316.158,319.243,323.043,324.64300000000003,326.778,330.813,334.613,336.812" svgx:width="0.53,0.28,0.2,0.29,0.2,0.41,0.5,0.2,0.55,0.53,0.5,0.28,0.42" style="fill:rgb(19,20,19);font-family:AdvTT1b53b5fb.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="149.329" x="342.255,345.895,349.536,353.176,356.882" svgx:width="0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">2016,</text>
   <text y="149.329" x="360.397,364.433,368.468,370.68,374.627,378.898,383.328,387.759,389.759,391.975,396.01,398.222" svgx:width="0.53,0.53,0.29,0.51,0.56,0.58,0.58,0.25,0.55,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">20(Suppl 2):</text>
   <text y="149.329" x="399.969,403.769,407.409,411.049" svgx:width="0.5,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">P103</text>
   <text y="167.358" x="304.781,306.861,311.357,314.101,316.933,321.429,326.005,330.501,334.077,336.821,338.74,343.236,347.732,351.06" svgx:width="0.26,0.56,0.34,0.35,0.56,0.57,0.56,0.45,0.34,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Introductions:</text>
   <text y="167.358" x="355.691,360.523,367.187,369.019,372.763,376.594,380.17,382.002,386.402,389.14,390.972,395.388,399.804,403.636,405.468,409.468,412.214,414.046,417.246,420.038,423.87,428.27,431.036,432.868,437.284,439.86,443.86,448.276,450.852,454.684,457.26,461.26,465.74,468.51,473.006,475.582,479.91,484.326,486.742,491.238,495.238,499.07,500.902,504.478,508.478,511.2,514.776,519.104,525.768,530.264,532.096,536.512" svgx:width="0.6,0.83,0.23,0.47,0.48,0.45,0.23,0.55,0.55,0.23,0.55,0.55,0.48,0.23,0.5,0.55,0.23,0.4,0.55,0.48,0.55,0.55,0.23,0.55,0.32,0.5,0.55,0.32,0.48,0.32,0.5,0.56,0.55,0.56,0.32,0.54,0.55,0.3,0.56,0.5,0.48,0.23,0.45,0.5,0.55,0.45,0.54,0.83,0.56,0.23,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Amikacin Inhale is an integrated drug-device combin-</text>
   <text y="176.315" x="304.781,308.613,311.189,313.021,317.349,321.74899999999997,325.814,330.142,332.47,334.07000000000005,338.173,342.421,346.749,348.581,355.245,359.573,363.989,367.711,370.287,374.04699999999997,378.142,383.39,385.966,390.294,394.69399999999996,398.779,404.027,408.027,409.859,411.691,415.523,419.523,422.099,425.859,429.903,433.815,437.559,440.719,443.295,447.295,453.935,458.023,460.271,464.519,469.767,475.015,478.927,481.175,482.77500000000003,486.823,490.655,492.487,496.982,499.558,503.39,505.966,507.798,512.214,516.614,520.669,527.332,531.332,534.492" svgx:width="0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.2,0.55,0.53,0.54,0.23,0.83,0.54,0.55,0.48,0.32,0.47,0.55,0.66,0.32,0.54,0.55,0.55,0.66,0.5,0.23,0.23,0.48,0.5,0.32,0.47,0.55,0.49,0.47,0.4,0.32,0.5,0.83,0.55,0.28,0.53,0.66,0.66,0.49,0.28,0.2,0.55,0.48,0.23,0.56,0.32,0.48,0.32,0.23,0.55,0.55,0.55,0.83,0.5,0.4,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ation of: Pulmonary Drug Delivery System (PDDS), vibrating mesh</text>
   <text y="185.329" x="304.781,309.197,313.197,317.693,322.021,323.853,325.685,329.101,333.101,335.661,338.173,342.973,345.6,348.76,353.256,357.256,360.832,362.664,366.496,368.328,370.16,373.92,376.385,378.713,383.041,385.617,392.281,396.609,398.441,402.272,404.848,408.848,413.32800000000003,415.899,420.731,427.395,429.227,432.971,436.803,440.278,442.11,446.51,449.121,450.953,455.369,459.785,463.617,465.449,469.281,471.857,473.689,477.921,482.32099999999997,484.951,488.863,493.191,495.023,499.351,501.927,503.759,508.087,512.487,514.999,517.247,522.079,523.911,527.823,530.063,532.631,534.463" svgx:width="0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.55,0.6,0.55,0.4,0.56,0.5,0.45,0.23,0.48,0.23,0.23,0.47,0.55,0.29,0.54,0.32,0.83,0.54,0.23,0.48,0.32,0.5,0.56,0.55,0.6,0.83,0.23,0.47,0.48,0.45,0.23,0.55,0.55,0.23,0.55,0.55,0.48,0.23,0.48,0.32,0.23,0.54,0.55,0.55,0.49,0.54,0.23,0.54,0.32,0.23,0.54,0.55,0.55,0.28,0.6,0.23,0.49,0.28,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">nebulizer &amp; specially formulated Amikacin Inhalation Solution (AIS) in</text>
   <text y="194.344" x="304.781,309.277,313.277,317.109,321.109,322.941,327.269,331.765,338.429,342.312,346.728,349.288,352.12,354.448,358.775,361.335,364.195,369.355,371.931,375.763,382.427,384.843,389.259,393.259,397.675,401.507,403.994,405.826,409.658,413.658,416.467,420.963,425.379,429.379,433.706,440.37,444.698,449.114,450.946,454.786,457.569,459.401,463.801,466.64,468.472,472.888,475.464,479.792,484.288,488.12,490.696,494.59,499.07,501.96,506.76,509.613,516.277,520.277,523.853,528.269,532.101,536.517" svgx:width="0.56,0.5,0.48,0.5,0.23,0.54,0.56,0.83,0.5,0.55,0.32,0.55,0.29,0.54,0.32,0.55,0.64,0.32,0.48,0.83,0.3,0.55,0.5,0.55,0.48,0.32,0.23,0.48,0.5,0.55,0.56,0.55,0.5,0.54,0.83,0.54,0.55,0.23,0.48,0.55,0.23,0.55,0.55,0.23,0.55,0.32,0.54,0.56,0.48,0.32,0.5,0.56,0.55,0.6,0.55,0.83,0.5,0.45,0.55,0.48,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">development for Gram-negative pneumonia in intubated &amp; mechan-</text>
   <text y="203.358" x="304.781,306.613,310.189,314.021,315.853,317.685,321.445,324.737,328.569,332.569,336.985,339.561,341.392,343.224,347.056,349.632,353.632,358.112,361.417,365.913,369.745,372.321,374.153,378.153,382.569,385.145,388.34499999999997,391.634,393.882,397.714,399.546,403.962" svgx:width="0.23,0.45,0.48,0.23,0.23,0.47,0.55,0.48,0.5,0.55,0.32,0.23,0.23,0.48,0.32,0.5,0.56,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.28,0.48,0.23,0.55,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ically ventilated patients (Fig.</text>
   <text y="203.358" x="408.868,412.948" svgx:width="0.51,0.51" style="fill:rgb(58,42,151);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">18</text>
   <text y="203.358" x="417.032,419.28,420.88,424.232,428.144,432.56,434.392,437.592,440.9,442.732,447.132,450.481,454.313,456.145,458.721,461.297,465.617,468.963,472.123,474.699,479.027,483.523,487.283,490.619,494.195,498.523,505.187,509.683,513.515,516.091,520.091,524.571,527.867,530.443,534.859" svgx:width="0.28,0.2,0.55,0.49,0.55,0.23,0.4,0.55,0.23,0.55,0.55,0.48,0.23,0.32,0.32,0.54,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.45,0.54,0.83,0.56,0.48,0.32,0.5,0.56,0.55,0.32,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">). This in vitro study compared the</text>
   <text y="212.315" x="304.781,309.277,313.277,315.109,316.941,320.773,324.773,327.349,331.349,335.829,340.611,345.107,349.435,352.595,356.595,361.474,365.802,368.122,372.982,377.814,379.646,383.56600000000003,388.403,390.731,393.307,397.635,404.275,409.152,411.728,416.144,420.144,425.027,429.275,434.522,439.77,443.69,448.497,452.329,455.529,460.403,463.979,468.307,474.971,481.635,485.635,488.211,491.698,493.53,497.362,499.194,501.026,504.786,509.613,513.445,517.277,521.109,522.941,524.773,528.604,533.1,534.932" svgx:width="0.56,0.5,0.23,0.23,0.48,0.5,0.32,0.5,0.56,0.55,0.56,0.54,0.4,0.5,0.55,0.54,0.29,0.55,0.6,0.23,0.49,0.55,0.29,0.32,0.54,0.83,0.55,0.32,0.55,0.5,0.55,0.53,0.66,0.66,0.49,0.55,0.48,0.4,0.55,0.45,0.54,0.83,0.83,0.5,0.32,0.45,0.23,0.48,0.23,0.23,0.47,0.55,0.48,0.48,0.48,0.23,0.23,0.48,0.56,0.23,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">delivered dose of AIS from the PDDS vs commercially available</text>
   <text y="221.33" x="304.781,309.197,313.197,317.693,322.021,323.853,325.685,329.101,333.101,335.565,338.725" svgx:width="0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">nebulizers.</text>
   <text y="217.758" x="340.328" svgx:width="0.51" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:5.33px;stroke:none;">1</text>
   <text y="230.343" x="304.781,311.357,315.437,318.181,322.677,327.173,331.749,334.998" svgx:width="0.82,0.51,0.34,0.56,0.56,0.57,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Methods:</text>
   <text y="230.343" x="339.817,345.065,349.065,350.897,352.729,356.561,360.561,363.137,366.897,369.808,374.136,376.456,379.39,384.222,386.054,389.974,392.939,395.187,399.267,403.347,407.42699999999996,410.344,417.008,421.424,423.024,425.991,430.071,431.647,435.727,438.69,445.354,449.114,452.013,456.341,458.661,461.65,465.73,469.81,473.89,476.844,483.508,487.924,490.588,497.251,500.995,503.235,506.154,511.986,515.818,519.018,521.914,525.49,529.818,536.482" svgx:width="0.66,0.5,0.23,0.23,0.48,0.5,0.32,0.47,0.55,0.54,0.29,0.55,0.6,0.23,0.49,0.55,0.28,0.51,0.51,0.51,0.55,0.83,0.55,0.2,0.55,0.51,0.2,0.51,0.55,0.83,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.51,0.55,0.83,0.55,0.33,0.83,0.47,0.28,0.55,0.73,0.48,0.4,0.55,0.45,0.54,0.83,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Delivery of AIS (400 mg; 3.2 mL of 125 mg/mL) was com-</text>
   <text y="239.358" x="304.781,309.277,313.109,315.685,319.685,324.165,327.231,329.559,333.887,336.447,339.59,342.166,346.582,350.582,353.707,357.955,363.203,368.451,372.37100000000004,375.42,379.252,382.452,385.568,389.144,393.472,400.136,406.8,410.8,413.376,416.863,418.695,422.527,424.359,426.191,429.95099999999996,433.02,436.852,440.684,444.516,446.348,448.18,452.012,456.508,458.34,462.34,465.392,467.304,471.304,473.879,475.47900000000004,478.601,482.929,484.761,487.337,489.913,493.745,496.905,501.233,505.649,507.401,511.00100000000003,514.148,518.476,521.036,524.126,527.702,532.03,536.446" svgx:width="0.56,0.48,0.32,0.5,0.56,0.55,0.29,0.54,0.32,0.55,0.32,0.55,0.5,0.55,0.53,0.66,0.66,0.49,0.55,0.48,0.4,0.55,0.45,0.54,0.83,0.83,0.5,0.32,0.45,0.23,0.48,0.23,0.23,0.47,0.55,0.48,0.48,0.48,0.23,0.23,0.48,0.56,0.23,0.5,0.55,0.24,0.5,0.32,0.2,0.55,0.54,0.23,0.32,0.32,0.48,0.4,0.54,0.55,0.23,0.45,0.55,0.54,0.32,0.55,0.45,0.54,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">pared for the PDDS vs commercially available jet, ultrasonic or con-</text>
   <text y="248.315" x="304.781,308.613,312.613,317.029,319.605,321.437,325.765,330.181,334.013,335.85299999999995,338.853,342.685,344.517,349.013,351.589,355.421,357.997,359.829,364.245,368.645,371.678,378.342,382.342,385.502,389.902,392.995,397.411,401.411,405.907,410.235,412.067,413.899,417.315,421.315,423.779,426.979,430.072,432.32,436.896,441.312,447.728,452.976,455.224,456.824,459.836,463.748,467.58,471.156,475.556,478.601,484.433,488.265,491.465,494.532,497.108,501.108,504.268,506.844,510.844,515.324,518.4,522.232,524.7919999999999,527.868,530.444,534.86" svgx:width="0.48,0.5,0.55,0.32,0.23,0.54,0.55,0.48,0.23,0.55,0.48,0.23,0.56,0.32,0.48,0.32,0.23,0.55,0.55,0.55,0.83,0.5,0.4,0.55,0.55,0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.4,0.55,0.28,0.57,0.55,0.8,0.66,0.28,0.2,0.55,0.49,0.48,0.45,0.55,0.55,0.73,0.48,0.4,0.55,0.32,0.5,0.4,0.32,0.5,0.56,0.55,0.48,0.32,0.55,0.32,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ventional vibrating mesh nebulizers (CVMN). Each was tested at the</text>
   <text y="257.329" x="304.781,308.613,312.613,317.029,319.605,321.437,323.269,327.101,329.677,334.005,336.565,341.291,343.123,347.451,351.027,354.859,357.435,359.267,363.595,367.995,372.698,375.858,380.354,384.354,387.93,389.762,392.09,393.922,397.922,402.40200000000004,407.111,408.943,413.34299999999996,418.109,419.941,422.517,425.717,430.411,432.243,436.659,439.819,442.395,444.971,449.299,452.875,455.451,457.283,461.611,465.958,469.158,473.895,476.223,480.551,483.111,487.898,493.058,496.218,500.218,504.962,507.21,509.042,512.874,518.034,520.282,521.8820000000001,526.562,530.474,534.89" svgx:width="0.48,0.5,0.55,0.32,0.23,0.23,0.48,0.32,0.54,0.32,0.55,0.23,0.54,0.45,0.48,0.32,0.23,0.54,0.55,0.55,0.4,0.56,0.5,0.45,0.23,0.29,0.23,0.5,0.56,0.55,0.23,0.55,0.55,0.23,0.32,0.4,0.55,0.23,0.55,0.4,0.32,0.32,0.54,0.45,0.32,0.23,0.54,0.55,0.4,0.55,0.29,0.54,0.32,0.55,0.64,0.4,0.5,0.55,0.28,0.23,0.48,0.64,0.28,0.2,0.55,0.49,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ventilator location specified in its Instructions for Use (IFU). The</text>
   <text y="266.344" x="304.781,309.357,313.773,320.189,325.469,328.875,334.707,338.539,341.739,345.203,347.779,351.779,354.939,357.515,361.515,365.995,369.467,373.299,375.859,379.389,383.469,386.929,389.257,393.585,396.161,398.737,403.153,407.152,409.712,413.234,417.73,422.058,425.218,427.05,429.626,431.458,435.786,440.202,443.282,444.882,448.384,452.296,455.96,459.536,463.536,468.032,470.592,474.066,476.394,480.722,483.282,486.822,489.398,493.814,497.814,501.278,505.854,510.27,516.686,521.966,525.429,529.925,532.501,536.501" svgx:width="0.57,0.55,0.8,0.66,0.55,0.73,0.48,0.4,0.55,0.32,0.5,0.4,0.32,0.5,0.56,0.55,0.48,0.32,0.55,0.51,0.55,0.29,0.54,0.32,0.32,0.55,0.5,0.32,0.55,0.56,0.54,0.4,0.23,0.32,0.23,0.54,0.55,0.4,0.2,0.55,0.49,0.46,0.45,0.5,0.56,0.32,0.55,0.29,0.54,0.32,0.55,0.32,0.55,0.5,0.55,0.57,0.55,0.8,0.66,0.55,0.56,0.32,0.5,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">CVMN was tested at 4 further positions. Except for the CVMN pre-</text>
   <text y="275.358" x="304.781,309.197,313.525,320.189,322.021,326.517,328.349,330.577,332.409,336.409,338.985,340.58500000000004,342.992,345.568,349.568,352.728,355.304,358.50399999999996,360.851,366.683,370.683,373.259,377.259,379.559,384.055,388.055,390.631,392.959,397.287,399.863,406.527,410.527,415.007,417.373,423.205,425.037,427.613,432.029,436.357,440.685,443.245,445.606,450.022,454.35,461.014,462.846,467.342,469.174,471.502,473.334,476.91,480.643,483.219,485.051,489.379,493.794" svgx:width="0.55,0.54,0.83,0.23,0.56,0.23,0.29,0.23,0.5,0.32,0.2,0.55,0.32,0.5,0.4,0.32,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.56,0.5,0.32,0.29,0.54,0.32,0.83,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.54,0.54,0.32,0.55,0.55,0.54,0.83,0.23,0.56,0.23,0.29,0.23,0.45,0.48,0.32,0.23,0.54,0.55,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">humidifier, tests were performed without humidification.</text>
   <text y="284.315" x="304.781,309.277,313.357,316.685,321.181,323.181,325.925,329.253" svgx:width="0.56,0.51,0.42,0.56,0.25,0.34,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Results:</text>
   <text y="284.315" x="335.112,339.528,341.36,345.856,348.432,352.264,354.84,356.672,361.087,365.48699999999997,369.524,376.188,380.188,383.348,387.748,391.805,396.221,400.221,404.717,409.044,410.876,412.708,416.012,420.012,422.588,425.788,429.846,432.094,436.342,441.59,446.838,450.75,452.35,456.321,460.897,465.313,471.729,476.977,479.217,483.251,487.083,490.659,495.075,496.907,500.906,504.738,508.738,513.218,517.266,521.682,523.514,527.93,532.346,536.346" svgx:width="0.55,0.23,0.56,0.32,0.48,0.32,0.23,0.55,0.55,0.55,0.83,0.5,0.4,0.55,0.55,0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.4,0.55,0.28,0.53,0.66,0.66,0.49,0.2,0.55,0.57,0.55,0.8,0.66,0.28,0.55,0.48,0.45,0.55,0.23,0.5,0.48,0.5,0.56,0.55,0.55,0.23,0.55,0.55,0.5,0.32" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Vibrating mesh nebulizers (PDDS, CVMN) achieved higher</text>
   <text y="293.33" x="304.781,309.277,313.277,315.109,316.941,320.773,324.773,327.349,331.349,335.829,338.797,343.292,347.62,350.78,354.78,357.97999999999996,360.963,363.539,367.955,371.787,376.18699999999995,379.218,383.546,385.378,387.954,390.53,394.362,397.522,401.85,406.266,408.019,411.619,414.652,416.9,420.97999999999996,424.006,430.334,432.574,435.628,439.46,443.876,448.356,451.389,453.301,457.301,459.861,462.897,465.145,469.225,473.305,476.333,482.661,484.901,487.955,492.371,496.371,500.867,505.195,507.027,508.859,512.275,516.275,518.851,521.914,523.514,526.563,530.475,534.891" svgx:width="0.56,0.5,0.23,0.23,0.48,0.5,0.32,0.5,0.56,0.55,0.56,0.54,0.4,0.5,0.4,0.55,0.32,0.55,0.48,0.55,0.55,0.54,0.23,0.32,0.32,0.48,0.4,0.54,0.55,0.23,0.45,0.55,0.28,0.51,0.55,0.79,0.28,0.55,0.48,0.55,0.56,0.55,0.24,0.5,0.32,0.55,0.28,0.51,0.51,0.55,0.79,0.28,0.55,0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.4,0.2,0.55,0.49,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">delivered doses than ultrasonic (4 %) and jet (11 %) nebulizers. The</text>
   <text y="302.344" x="304.781,309.277,313.277,315.109,316.941,320.773,324.773,327.349,331.349,335.829,339.76,344.256,348.584,351.744,355.744,359.773,364.101,366.421,370.431,375.263,377.095,381.01500000000004,385.002,389.497,393.825,396.985,399.561,401.977,405.889,409.809,413.801,416.377,420.705,425.201,429.201,433.19,439.022,442.854,446.054,449.971,454.387,456.219,460.635,465.051,469.051,471.611,475.596,481.428,483.26,485.836,490.236,494.248,496.824,501.24,505.24,509.272,513.52,518.768,524.016,527.9359999999999,531.892,535.724" svgx:width="0.56,0.5,0.23,0.23,0.48,0.5,0.32,0.5,0.56,0.55,0.56,0.54,0.4,0.5,0.55,0.54,0.29,0.55,0.6,0.23,0.49,0.55,0.56,0.54,0.4,0.32,0.3,0.49,0.49,0.55,0.32,0.54,0.56,0.5,0.55,0.73,0.48,0.4,0.55,0.55,0.23,0.55,0.55,0.5,0.32,0.55,0.73,0.23,0.32,0.55,0.55,0.32,0.55,0.5,0.55,0.53,0.66,0.66,0.49,0.55,0.48,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">delivered dose of AIS post-ET tube was higher with the PDDS vs</text>
   <text y="311.358" x="304.781,309.357,313.773,320.189,325.469,327.912,330.16,334.24,338.32,340.781,347.101,349.625,353.457,356.657,359.093,363.173,367.253,369.751,376.07099999999997,378.595,382.923,385.243,387.779,392.195,396.523,403.187,405.019,409.435,413.267,414.992,417.24,418.84000000000003,421.341,426.501,430.981,433.53,436.106,440.426,442.941,447.021,451.101,453.599,459.919,462.443,466.771,469.091,471.571,476.403,478.235,482.15500000000003,484.667,490.499,494.331,497.531,499.974,503.55,507.878,509.71,511.542,515.542,519.117,521.693,525.693,530.173,532.629,534.461" svgx:width="0.57,0.55,0.8,0.66,0.55,0.28,0.51,0.51,0.55,0.79,0.55,0.48,0.4,0.55,0.51,0.51,0.55,0.79,0.55,0.54,0.29,0.55,0.55,0.54,0.83,0.23,0.55,0.48,0.23,0.28,0.2,0.55,0.64,0.56,0.55,0.32,0.54,0.55,0.51,0.51,0.55,0.79,0.55,0.54,0.29,0.55,0.6,0.23,0.49,0.55,0.73,0.48,0.4,0.55,0.45,0.54,0.23,0.23,0.5,0.45,0.32,0.5,0.56,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">CVMN (57 % vs 19 % of nominal). Up to 60 % of AIS was collected in</text>
   <text y="320.316" x="304.781,307.357,311.773,315.773,318.614,322.614,326.278,330.774,332.606,335.182,339.014,341.59,345.918,348.494,352.254,355.068,357.396,359.228,361.06,363.636,367.636,370.196,373.097,378.929,380.761,383.337,387.73699999999997,390.615,393.191,397.607,401.607,404.448,409.024,413.44,419.856,425.13599999999997,427.976,431.808,435.008,437.841,441.921,444.814,451.134,453.998,456.326,460.654,463.214,466.131,468.707,473.123,477.123,479.964,484.212,489.46,494.708,498.62,500.22,503.038,506.95,511.366,515.366,518.232,522.808,527.224,533.64" svgx:width="0.32,0.55,0.5,0.55,0.5,0.46,0.56,0.23,0.32,0.48,0.32,0.54,0.32,0.47,0.55,0.29,0.23,0.23,0.32,0.5,0.32,0.55,0.73,0.23,0.32,0.55,0.55,0.32,0.55,0.5,0.55,0.57,0.55,0.8,0.66,0.55,0.48,0.4,0.55,0.51,0.55,0.79,0.55,0.29,0.54,0.32,0.55,0.32,0.55,0.5,0.55,0.53,0.66,0.66,0.49,0.2,0.55,0.49,0.55,0.5,0.55,0.57,0.55,0.8,0.66" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">the expiratory filter with the CVMN vs 3 % for the PDDS. The CVMN</text>
   <text y="329.33" x="304.781,309.197,313.029,317.509,320.315,322.147,328.811,333.307,335.883,340.211,344.043,348.043,352.523,355.238,359.734,363.734,368.23,372.558,375.718,377.55,380.126,381.958,386.285,390.685,393.449,395.697,400.025,404.505,407.338,409.914,414.234,417.032,421.112,425.192,427.974,434.302,436.54200000000003,439.369,443.201,445.761,448.553,451.129,455.545,459.545,462.329,466.329,469.993,472.569,475.145,478.98499999999996,481.775,483.607,487.935,491.51,495.342,497.918,499.75,504.078,508.494,511.694,514.429,517.005,521.005,522.837,526.669,529.245,531.077,534.909" svgx:width="0.55,0.48,0.56,0.55,0.23,0.83,0.56,0.32,0.54,0.48,0.5,0.56,0.55,0.56,0.5,0.56,0.54,0.4,0.23,0.32,0.23,0.54,0.55,0.55,0.28,0.54,0.56,0.55,0.32,0.54,0.55,0.51,0.51,0.55,0.79,0.28,0.55,0.48,0.32,0.55,0.32,0.55,0.5,0.55,0.5,0.46,0.32,0.32,0.48,0.55,0.23,0.54,0.45,0.48,0.32,0.23,0.54,0.55,0.4,0.55,0.32,0.5,0.23,0.48,0.32,0.23,0.48,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">had improved deposition (up to 29 %) at the extra locations relative</text>
   <text y="338.344" x="304.781,307.357,311.677,314.589,316.421,320.253,325.373,328.365,332.861,337.189,340.349,342.181,344.757,346.589,350.917,355.31699999999995,358.243,362.739,367.067,369.627,372.586,375.162,379.578,381.41,384.61,387.496,393.328,397.16,400.36,403.2,406.36,408.936,410.768,412.6,414.44,417.373,419.205,423.533,429.365,433.365,435.925,438.86,441.436,445.852,449.684,454.084,457.001,462.833,464.665,467.241,471.64099999999996,474.576,477.152,481.568,485.568,488.523,492.771,498.019,503.266,507.18600000000004,510.066,512.314,516.146,517.977,522.393" svgx:width="0.32,0.54,0.55,0.23,0.48,0.64,0.55,0.56,0.54,0.4,0.23,0.32,0.23,0.54,0.55,0.55,0.56,0.54,0.32,0.55,0.32,0.55,0.23,0.4,0.55,0.73,0.48,0.4,0.55,0.4,0.32,0.23,0.23,0.23,0.55,0.23,0.54,0.73,0.5,0.32,0.55,0.32,0.55,0.48,0.55,0.55,0.73,0.23,0.32,0.55,0.55,0.32,0.55,0.5,0.55,0.53,0.66,0.66,0.49,0.55,0.28,0.48,0.23,0.55,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">to IFU position but this was still lower than with the PDDS (Fig.</text>
   <text y="338.344" x="526.903,530.983" svgx:width="0.51,0.51" style="fill:rgb(58,42,151);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">19</text>
   <text y="338.344" x="535.01,537.258" svgx:width="0.28,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">).</text>
   <text y="347.359" x="304.781,310.029,314.029,315.861,317.693,321.525,325.525,328.101,331.993,336.473,339.42,343.916,348.244,351.404,355.404,358.299,364.131,365.963,368.539,372.93899999999996,375.874,378.45,382.866,386.866,389.764,394.34,398.756,405.172,410.452,413.292,419.124,422.955,426.155,428.995,432.827,435.155,437.483,441.483,445.059,447.635,451.635,456.115,459.043,463.539,467.299,470.212,474.628,478.956,485.619,487.451,491.947,493.779,496.355,500.099,501.699,504.511,510.343,514.759,516.591,520.167,524.567,527.472,531.888,535.72" svgx:width="0.66,0.5,0.23,0.23,0.48,0.5,0.32,0.5,0.56,0.55,0.56,0.54,0.4,0.5,0.55,0.73,0.23,0.32,0.55,0.55,0.32,0.55,0.5,0.55,0.57,0.55,0.8,0.66,0.55,0.73,0.48,0.4,0.55,0.48,0.29,0.29,0.5,0.45,0.32,0.5,0.56,0.55,0.56,0.47,0.55,0.55,0.54,0.83,0.23,0.56,0.23,0.32,0.47,0.2,0.55,0.73,0.55,0.23,0.45,0.55,0.55,0.55,0.48,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Delivered dose with the CVMN was affected by humidity, which has</text>
   <text y="356.316" x="304.781,309.277,311.853,315.853,319.685,321.517,325.845,330.173,333.241,335.073,338.83299999999997,341.234,345.73,349.73,353.73,358.13,360.51,363.67,368.086,372.414,378.246,382.64599999999996,385.001,389.417,393.745,396.305,398.664,401.24,405.56,407.961,411.793,414.121,416.449,420.449,424.025,426.585,428.995,433.243,438.491,443.738,447.658,449.971,454.467,458.467,461.043,463.371,467.699,470.275,476.939,480.771,485.187,488.763,492.763" svgx:width="0.56,0.32,0.5,0.48,0.23,0.54,0.54,0.4,0.23,0.47,0.55,0.56,0.5,0.5,0.55,0.55,0.4,0.55,0.54,0.73,0.55,0.55,0.55,0.54,0.32,0.55,0.32,0.54,0.55,0.48,0.29,0.29,0.5,0.45,0.32,0.55,0.53,0.66,0.66,0.49,0.55,0.56,0.5,0.32,0.29,0.54,0.32,0.83,0.48,0.55,0.45,0.5,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">previously been shown not to affect PDDS performance.</text>
   <text y="352.8" x="494.249" svgx:width="0.51" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:5.33px;stroke:none;">2</text>
   <text y="365.329" x="304.781,309.445,313.941,318.437,322.013,324.013,328.509,331.837,333.837,338.23,342.726,346.054" svgx:width="0.58,0.56,0.56,0.45,0.25,0.56,0.42,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Conclusions:</text>
   <text y="365.329" x="352.063,356.895,363.559,365.391,369.135,372.967,376.542,378.374,382.774,386.872,388.704,393.12,397.536,401.368,403.2,407.2,411.307,413.555,418.387,420.219,424.139,428.315,432.811,436.811,438.642,440.474,444.306,448.306,450.882,454.882,459.362,463.465,467.96,471.71999999999997,475.88,480.128,485.376,490.624,494.536,496.776,500.882,505.378,507.954,512.281,516.113,517.945,522.441,526.441,530.921,535.068" svgx:width="0.6,0.83,0.23,0.47,0.48,0.45,0.23,0.55,0.55,0.23,0.55,0.55,0.48,0.23,0.5,0.55,0.28,0.6,0.23,0.49,0.55,0.56,0.5,0.23,0.23,0.48,0.5,0.32,0.5,0.56,0.55,0.56,0.47,0.55,0.53,0.66,0.66,0.49,0.28,0.55,0.56,0.32,0.54,0.48,0.23,0.56,0.5,0.56,0.55,0.48" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Amikacin Inhale (AIS delivered by PDDS) provided a</text>
   <text y="374.343" x="304.781,309.197,311.029,315.445,319.861,323.861,326.421,328.762,333.258,337.258,339.09,340.922,344.754,348.754,351.33,355.33,359.81,362.155,366.651,370.978,374.138,378.138,380.523,384.851,387.171,389.537,394.369,396.201,400.12100000000004,402.52,406.352,409.55199999999996,411.875,415.451,419.779,426.443,433.106,437.106,439.682,443.17,445.001,448.833,450.665,452.497,456.257,458.647,462.479,466.311,470.143,471.975,473.807,477.639,482.135,483.967,487.967,490.282,494.698,498.698,503.193,507.521,509.353,511.185,514.601,518.601,521.066,524.226" svgx:width="0.55,0.23,0.55,0.55,0.5,0.32,0.55,0.56,0.5,0.23,0.23,0.48,0.5,0.32,0.5,0.56,0.55,0.56,0.54,0.4,0.5,0.55,0.54,0.29,0.55,0.6,0.23,0.49,0.55,0.48,0.4,0.55,0.45,0.54,0.83,0.83,0.5,0.32,0.45,0.23,0.48,0.23,0.23,0.47,0.55,0.48,0.48,0.48,0.23,0.23,0.48,0.56,0.23,0.5,0.55,0.55,0.5,0.56,0.54,0.23,0.23,0.43,0.5,0.32,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">higher delivered dose of AIS vs commercially available nebulizers.</text>
   <text y="392.315" x="304.781,308.996,312.821,315.161,318.986,321.641,325.466,329.681,333.033,336.858" svgx:width="0.56,0.51,0.31,0.51,0.35,0.51,0.56,0.45,0.51,0.42" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:7.5px;stroke:none;">References</text>
   <text y="401.329" x="304.781,308.373,309.64799999999997,316.743,320.411,323.763,327.821,330.003,331.653,334.931,338.913,342.813,345.032,348.625,350.875,353.196,356.548,358.108,359.383,361.587,364.137,366.405,370.778,374.37,376.553,380.535,383.265,387.325,388.9,391.123,396.898,400.491,404.541,406.827,410.577,414.477,416.037,422.11199999999997,424.402,429.239,431.422,435.322,439.372,441.637,446.474,450.067,451.642,453.939,457.531,461.124,464.716,468.309,469.553,473.146,476.738,477.983,481.733,485.326,488.918" svgx:width="0.48,0.17,0.55,0.49,0.45,0.54,0.29,0.21,0.44,0.53,0.52,0.55,0.48,0.3,0.55,0.45,0.21,0.17,0.55,0.34,0.55,0.58,0.48,0.29,0.53,0.36,0.53,0.21,0.55,0.77,0.48,0.54,0.55,0.5,0.52,0.21,0.81,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.5,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">1. Kadrichu et al. J Aerosol Med Pulm Drug Del 2013;26:P054</text>
   <text y="410.343" x="304.781,308.373,309.64799999999997,316.743,320.411,323.763,327.821,330.003,331.653,334.931,338.913,342.813,345.032,348.625,350.875,353.196,356.548,358.108,359.383,361.587,363.147,367.129,369.394,372.987,376.969,379.699,381.259,384.611,388.211,390.499,394.714,398.067,400.249,403.84900000000005,406.146,411.921,415.514,419.564,421.85,425.443,429.035,432.628,436.22,437.465,441.058,444.65,446.6,450.035,453.628,455.577,456.822,460.572,464.165,467.757,471.35" svgx:width="0.48,0.17,0.55,0.49,0.45,0.54,0.29,0.21,0.44,0.53,0.52,0.55,0.48,0.3,0.55,0.45,0.21,0.17,0.55,0.21,0.53,0.3,0.48,0.53,0.36,0.21,0.45,0.48,0.55,0.56,0.45,0.29,0.48,0.55,0.77,0.48,0.54,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.46,0.48,0.26,0.17,0.5,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:7.5px;stroke:none;">2. Kadrichu et al. Intensive Care Med 2014:40(S1):P0867</text>
  </g>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:1.0;" d="M308.750 565.230 L534.840 565.230 L534.840 565.460 L308.750 565.460 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M534.840 565.230 L535.580 565.290 C537.140 565.460 538.620 567.000 538.810 568.520 L538.870 569.200 L538.640 569.200 L538.580 568.570 C538.360 567.110 536.990 565.730 535.520 565.510 L534.840 565.460 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M538.870 569.200 L538.870 727.310 L538.640 727.310 L538.640 569.200 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M538.870 727.310 L538.810 728.050 C538.610 729.610 537.070 731.050 535.580 731.280 L534.840 731.340 L534.840 731.060 L535.520 731.000 C537.070 730.800 538.290 729.490 538.580 727.990 L538.640 727.310 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M534.840 731.340 L308.750 731.340 L308.750 731.060 L534.840 731.060 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M308.750 731.340 L308.070 731.280 C306.490 730.980 305.070 729.690 304.840 728.050 L304.780 727.310 L305.010 727.310 L305.070 727.990 C305.360 729.490 306.580 730.800 308.130 731.000 L308.750 731.050 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M304.780 727.310 L304.780 569.200 L305.010 569.200 L305.010 727.310 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M304.780 569.200 L304.840 568.520 C305.080 566.890 306.440 565.520 308.070 565.290 L308.750 565.230 L308.750 565.460 L308.130 565.510 C306.660 565.730 305.280 567.110 305.060 568.570 L305.010 569.200 "/>
  <rect style="stroke:blue;stroke-width:0.3;" x="314.192" y="580.599" height="143.603" width="215.207" title="36"/>
  <text y="580.599" class="image" id="image.36.1" width="215" height="143" x="314.192">image.36.1.314_529.581_724</text>
  <g begin="text">
   <text y="726.066" x="310.79,314.79,316.79,321.366,323.20599999999996,325.53,329.778,334.01800000000003,336.415,338.743,343.823,348.487,351.815,354.559,357.391,361.391,364.967,367.687,370.034,374.45,378.698,382.946,387.194,389.522" svgx:width="0.5,0.25,0.57,0.23,0.55,0.53,0.53,0.55,0.29,0.63,0.58,0.42,0.34,0.35,0.5,0.45,0.34,0.55,0.55,0.53,0.53,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Fig. 19 (Abstract P103).</text>
   <text y="726.066" x="393.732,397.732,401.564,403.892,405.972,410.22,412.548,419.044,422.532,426.78,430.276,434.116,436.479,440.726,442.806,445.21,449.21,454.37,459.529,463.209,465.562,469.138,472.05,473.41,475.767,480.263,484.263,490.423,495.503" svgx:width="0.5,0.48,0.29,0.26,0.53,0.29,0.81,0.45,0.53,0.44,0.48,0.55,0.53,0.26,0.55,0.5,0.64,0.64,0.46,0.55,0.45,0.36,0.17,0.55,0.56,0.5,0.77,0.63,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Performance of PDDS vs. CVMN.</text>
  </g>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M308.750 430.190 L534.840 430.190 L534.840 430.410 L308.750 430.410 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M534.840 430.190 L535.580 430.240 C537.140 430.420 538.620 431.960 538.810 433.470 L538.870 434.160 L538.640 434.160 L538.580 433.530 C538.360 432.070 536.990 430.690 535.520 430.470 L534.840 430.410 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M538.870 434.150 L538.870 547.310 L538.640 547.310 L538.640 434.150 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M538.870 547.310 L538.810 548.050 C538.610 549.610 537.070 551.050 535.580 551.280 L534.840 551.340 L534.840 551.060 L535.520 551.000 C537.070 550.800 538.290 549.490 538.580 547.990 L538.640 547.310 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M534.840 551.340 L308.750 551.340 L308.750 551.060 L534.840 551.060 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M308.750 551.340 L308.070 551.280 C306.490 550.980 305.070 549.690 304.840 548.050 L304.780 547.310 L305.010 547.310 L305.070 547.990 C305.360 549.490 306.580 550.800 308.130 551.000 L308.750 551.060 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M304.780 547.310 L304.780 434.150 L305.010 434.150 L305.010 547.310 "/>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:0.25;" d="M304.780 434.150 L304.840 433.470 C305.080 431.840 306.440 430.480 308.070 430.240 L308.750 430.190 L308.750 430.410 L308.130 430.470 C306.660 430.690 305.280 432.070 305.060 433.530 L305.010 434.150 "/>
  <rect style="stroke:blue;stroke-width:0.3;" x="314.192" y="445.556" height="89.631" width="215.207" title="36"/>
  <text y="445.556" class="image" id="image.36.2" width="215" height="89" x="314.192">image.36.2.314_529.446_535</text>
  <g begin="text">
   <text y="537.052" x="310.79,314.79,316.79,321.366,323.20599999999996,325.53,329.778,334.01800000000003,336.415,338.743,343.823,348.487,351.815,354.559,357.391,361.391,364.967,367.687,370.034,374.45,378.698,382.946,387.194,389.522" svgx:width="0.5,0.25,0.57,0.23,0.55,0.53,0.53,0.55,0.29,0.63,0.58,0.42,0.34,0.35,0.5,0.45,0.34,0.55,0.55,0.53,0.53,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Fig. 18 (Abstract P103).</text>
   <text y="537.052" x="393.732,398.396,404.892,406.556,409.884,413.46,416.956,418.62,422.86,425.196,426.86,431.108,435.356,438.932,440.596,444.428,445.788,448.1,451.676,455.916,458.305,459.969,464.217,466.633,470.464,474.792,477.12,480.696,483.112,486.944" svgx:width="0.58,0.81,0.21,0.42,0.45,0.44,0.21,0.53,0.55,0.21,0.53,0.53,0.45,0.21,0.48,0.17,0.55,0.45,0.53,0.55,0.21,0.53,0.3,0.48,0.54,0.29,0.45,0.3,0.48,0.54" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Amikacin Inhale, an integrated</text>
   <text y="546.066" x="310.791,315.118,317.446,321.606,325.934,328.262,332.59,336.422,339.998,341.575,345.071,348.911,351.269,354.765,359.013,365.509,369.837,371.501,375.749,379.325,381.741,383.405,387.653,391.901" svgx:width="0.54,0.29,0.52,0.54,0.29,0.54,0.48,0.45,0.21,0.44,0.48,0.55,0.44,0.53,0.81,0.54,0.21,0.53,0.45,0.3,0.21,0.53,0.53,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">drug-device combination.</text>
   <text y="39.007" x="56.524,60.94,63.436,65.18,67.676,69.42,72.748,76.908,78.668,81.016,85.432,89.592,92.088" svgx:width="0.55,0.31,0.22,0.31,0.22,0.42,0.52,0.22,0.55,0.55,0.52,0.31,0.45" style="fill:rgb(19,20,19);font-family:AdvTT7329fd89.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="39.007" x="98.023,102.103,106.183,110.263,114.343,115.943,118.263,122.678,127.006,128.838,133.166,139.83,143.83,146.156,150.236,154.316,156.7,160.612,164.94,169.436,173.932,175.772,178.131,182.211,488.238,492.486,496.318,500.734,504.734,507.06,511.14,515.22,517.605,521.933,524.253,526.676,530.756,534.836" svgx:width="0.51,0.51,0.51,0.51,0.2,0.55,0.55,0.54,0.23,0.54,0.83,0.5,0.55,0.51,0.51,0.55,0.49,0.54,0.56,0.56,0.23,0.55,0.51,0.55,0.53,0.48,0.55,0.5,0.55,0.51,0.51,0.55,0.54,0.29,0.55,0.51,0.51,0.51" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">2016, Volume 20 Suppl 2 Page 48 of 182</text>
  </g>
 </g>
</svg>
